Attachment B - Testing Locations.xlsx
XLSX spreadsheet 125 KB Posted
- Solicitation number
- 36C24822R0071
About this file
This document outlines an estimated quantities solicitation from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 for reference laboratory testing services. Key details include an estimated annual testing volume of $87 million maximum, with a minimum guaranteed contract value of $11 million over the base year and any exercised option years. Testing services will be ordered via task orders issued at the start of each performance period. Pricing will be established within the contract terms.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C24822R0071 0002.docx | DOCX document | |
| Attachment D - VISN8 Reference Lab Line Items - Cost Per Test - MultiStation dated 7.28.2022.xlsx | XLSX spreadsheet | |
| 36C24822R0071 0001.docx | DOCX document | |
| Attachment F - Contractor-provided Specimen Processor Sites_5-10-21.docx | DOCX document | |
| Attachment E - Locations (VISN8 Map).pdf | ||
| Attachment H - Wage Determination.docx | DOCX document | |
| Attachment G - Contractor Rules Of Behavior.pdf | ||
| Attachment D - VISN8 Reference Lab Line Items - Cost Per Test - MultiStation.xlsx | XLSX spreadsheet | |
| Attachment A - Sub-Contracting Model Plan.docx | DOCX document | |
| Attachment I -Compliance and Business Integrity (CBI) - only if awarded.docx | DOCX document | |
| SCHEDULE.xlsx | XLSX spreadsheet | |
| 36C24822R0071.docx | DOCX document | |
| Attachment J Ref Lab Test List Vendor Panel Match.xlsx | XLSX spreadsheet | |
| Attachment C - PP Evaluation Questionnaire.docx | DOCX document |
Show all 14
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Tests
| A | B | C | D | E | |
| Item # | Tests | Test Name (if different from column A) | Location (city and state) of facility the test will be conducted | Is this facility owned and operated by the offeror? Yes/No If answer is "No", complete column E | Name of the company that will be performing the test |
| 1 | **17-HYDROXYPROGESTER | ||||
| 2 | **ALCOHOL MET CONFIRM | ||||
| 3 | **ALCOHOL METAB, QN, UR | ||||
| 4 | **BENZODIAZEPINES CONF | ||||
| 5 | **DM ALC METAB U | ||||
| 6 | **DM ALC METAB U | ||||
| 7 | **DM AMPHETAMINES QN U | ||||
| 8 | **DM BARBITURATES QN U | ||||
| 9 | **DM BENZO QN U | ||||
| 10 | **DM BENZO QN U | ||||
| 11 | **DM BUP, QN, URINE | ||||
| 12 | **DM FENTANYL,QN,U | ||||
| 13 | **DM FENTANYL,QN,U | ||||
| 14 | **DM MARIJUANA M QN U | ||||
| 15 | **DM ME METAB QN U | ||||
| 16 | **DM MPHENIDATE M,QN,U | ||||
| 17 | **DM MPHENIDATE M,QN,U | ||||
| 18 | **DM OPI EXPANDED QN U | ||||
| 19 | **DM OPI EXPANDED QN U | ||||
| 20 | **DM OXYCODONE QN U | ||||
| 21 | **DM TRAMADOL,QN,U | ||||
| 22 | **DOXEPIN, QUANT. | ||||
| 23 | **DRUG COCAINE MET QN U | ||||
| 24 | **DRUG COCAINE MET QN U | ||||
| 25 | **DTM CONF BENZO, ORAL FL | ||||
| 26 | **DTM CONF COC, ORAL FL | ||||
| 27 | **DTM CONF NIC, ORAL FL | ||||
| 28 | **DTM CONF OPI, ORAL FL | ||||
| 29 | **DTM CONF THC, ORAL FL | ||||
| 30 | **EHRLICHIA CHAFFEENSIS | ||||
| 31 | **ETHYL GLUCURONIDE CONF | ||||
| 32 | **FACTOR XIII FUNCTIONAL | ||||
| 33 | **GLIADIN ANTIBODY,IGG | ||||
| 34 | **LIPOPROTEIN A (LP(A)) | ||||
| 35 | **MORPHINE-TOTAL(CONJ. & | ||||
| 36 | **OPIATES CONFIRMATION | ||||
| 37 | **PLASMA CELL PROLIF,FISH | ||||
| 38 | **QBS CLIENT BTT SERV CD | ||||
| 39 | **SELENIUM, BLOOD | ||||
| 40 | **STRONGYLOIDES ANTIBODY | ||||
| 41 | 11-DEOXYCORTISOL,LC/MS/MS | ||||
| 42 | 14-3-3 ETA PROTEIN | ||||
| 43 | 14-3-3 PROTEIN, CSF | ||||
| 44 | 17-HYDROXYCORTICOSTEROIDS | ||||
| 45 | 17-HYDROXYCORTICOSTEROIDS | ||||
| 46 | 17-HYDROXYPROGESTERONE | ||||
| 47 | 17-KETOSTEROIDS W/CREAT | ||||
| 48 | 2,3 DINOR 11B PROS | ||||
| 49 | 21-HYDROXYLASE ANTIBODY | ||||
| 50 | 4K PROSTATE SCORE (SERUM) | ||||
| 51 | 5 HIAA | ||||
| 52 | 5 NUCLEOTIDASE | ||||
| 53 | 5' NUCLEOTIDASE | ||||
| 54 | 5-HIAA W/CREATININE 24 HR | ||||
| 55 | 5HIAA(SEROTONIN) | ||||
| 56 | 5-HIAA, 24 HR URINE | ||||
| 57 | 5-HIAA, 24-HOUR URINE | ||||
| 58 | 5-HIAA, RANDOM URINE | ||||
| 59 | 6-MONOACETYLMORPHINE | ||||
| 60 | A. FUMIGATUS (M3) | ||||
| 61 | A. FUMIGATUS (M3) IGE | ||||
| 62 | A. PHAGOCYTOPHILUM/E. CHA | ||||
| 63 | A. TENUIS (M6) IGE | ||||
| 64 | A-1 ANTITRYPSIN MUTATION | ||||
| 65 | A1A, FECES, RANDOM | ||||
| 66 | A1AT PHENOTYPE | ||||
| 67 | AAC, IHC W/O INTERP | ||||
| 68 | AAT, IHC W/O INTERP | ||||
| 69 | ABL KINASE DOMAIN | ||||
| 70 | ABL MUTATION,CELL-BASED | ||||
| 71 | ACACIA (T19) IGE | ||||
| 72 | ACARUS SIRO (D70) IGE | ||||
| 73 | ACCUTYPE CP,CLOPIDOGREL | ||||
| 74 | ACCUTYPE(R) IL28B | ||||
| 75 | ACE, CSF | ||||
| 76 | ACE, SERUM | ||||
| 77 | ACETONE | ||||
| 78 | ACETYLCHOLINE REC BINDING | ||||
| 79 | ACETYLCHOLINE REC BLOC AB | ||||
| 80 | ACETYLCHOLINE REC MOD AB | ||||
| 81 | ACETYLCHOLINE REC MOD AB | ||||
| 82 | ACETYLCHOLINE RECEPTOR | ||||
| 83 | ACETYLCHOLINE RECEPTOR | ||||
| 84 | ACETYLCHOLINE RECEPTOR BL | ||||
| 85 | ACID FAST STAIN | ||||
| 86 | ACID FAST STAIN, TISS | ||||
| 87 | ACID-FAST BACILLI ID, | ||||
| 88 | ACTH, PLASMA | ||||
| 89 | ACTH, PLASMA | ||||
| 90 | ACTIN ANTIBODY (IGG) | ||||
| 91 | ACTIN ANTIBODY (IGG) | ||||
| 92 | ACTIVATED PROTEIN C RESIS | ||||
| 93 | ADA, PLEURAL FLUID | ||||
| 94 | ADALIMUMAB ADA IBD | ||||
| 95 | ADALIMUMAB LEVEL/ADA, IBD | ||||
| 96 | ADALIMUMAB LVL & ANTI-DR | ||||
| 97 | ADAMTS13 ACTIVITY W/REFLE | ||||
| 98 | ADAMTS13 ACTIVITY W/RFL | ||||
| 99 | ADAMTS13 INHIBITOR | ||||
| 100 | ADENOSINE DEAMINASE, CSF | ||||
| 101 | ADENOSINE DEAMINASE, CSF | ||||
| 102 | ADENOSINE DEAMINASE, PERI | ||||
| 103 | ADENOSINE DEAMINASE, PLEU | ||||
| 104 | ADENOVIRUS ANTIBODY GROUP | ||||
| 105 | ADENOVIRUS ANTIBODY,SERUM | ||||
| 106 | ADENOVIRUS CULTURE | ||||
| 107 | ADMARK APOE GENOTYPE | ||||
| 108 | ADRENAL AB | ||||
| 109 | ADRENAL AB SCREEN W/ RFLX | ||||
| 110 | ADV LIPID PNL | ||||
| 111 | AEROBIC MIC 1 | ||||
| 112 | AEROBIC SUSC (1) | ||||
| 113 | AFB CULT BLD PROG ID&SENS | ||||
| 114 | AFB CULT,PROBES,ID,SENS | ||||
| 115 | AFB ID, SEQ.&STAIN,PARAFF | ||||
| 116 | AFB SEQUENCING 1 | ||||
| 117 | AFB/PROBE | ||||
| 118 | AFB1 MALDI ID 1 | ||||
| 119 | AFP, IHC W/O INTERP | ||||
| 120 | ALBUMIN, CSF | ||||
| 121 | ALBUMIN, PERITONEAL FLUID | ||||
| 122 | ALBUMIN, PLEURAL FLUID | ||||
| 123 | ALCOHOL, ISOPROPYL | ||||
| 124 | ALDO/PRA RATIO,LC/MS/MS | ||||
| 125 | ALDOLASE | ||||
| 126 | ALDOLASE, SERUM | ||||
| 127 | ALDOSTERONE | ||||
| 128 | ALDOSTERONE 24 HR URINE | ||||
| 129 | ALDOSTERONE, LC/MS | ||||
| 130 | ALDOSTERONE, URINE | ||||
| 131 | ALDOSTERONE/PLASMA RENIN | ||||
| 132 | ALK 1, IHC W/INTERP | ||||
| 133 | ALK 1, IHC W/O INTERP | ||||
| 134 | ALK 1,IHC W/O INTERP | ||||
| 135 | ALK. PHOSPHATASE ISO 2 | ||||
| 136 | ALK. PHOSPHATASE,BONE | ||||
| 137 | ALKALINE PHOSPHATASE | ||||
| 138 | ALLERGY - INSECT VENOM | ||||
| 139 | ALLERGY 13,INSCT | ||||
| 140 | ALLERGY PANEL #13 | ||||
| 141 | ALLERGY PANEL 19, SEAFOOD | ||||
| 142 | ALLERGY REG. PROFILE | ||||
| 143 | ALLERGY SEAFOOD PANEL WIT | ||||
| 144 | ALLERGY SHELLFISH PANEL 1 | ||||
| 145 | ALLERGY,DUST PROFILE | ||||
| 146 | ALLERGY,INSECT VENOM PANL | ||||
| 147 | ALLERGY,SEAFOOD/SHELLFISH | ||||
| 148 | ALLERGY-MAJOR FOOD | ||||
| 149 | ALLERGY-MOLD PROFILE + | ||||
| 150 | ALLERGY-NUT PANEL | ||||
| 151 | ALLERGY-STINGING INSECT | ||||
| 152 | ALMOND (F20) IGE | ||||
| 153 | ALMOND (F20) IGE | ||||
| 154 | ALPHA 1 ANTI-TRYPSIN | ||||
| 155 | ALPHA 1-ANTITRYPSIN 24HR | ||||
| 156 | ALPHA 1-ANTITRYPSIN, RND | ||||
| 157 | ALPHA 3 AB | ||||
| 158 | ALPHA SUBUNIT | ||||
| 159 | ALPHA SUBUNIT | ||||
| 160 | ALPHA-1-ANTITRYPSIN (AAT) | ||||
| 161 | ALPHA-1-ANTITRYPSIN PHENO | ||||
| 162 | ALPHA-2-MACROGLOBULIN | ||||
| 163 | ALPHA-FETOPROTEIN (AFP) | ||||
| 164 | ALPHA-GALACTOSIDAS | ||||
| 165 | ALPHA-GALACTOSIDASE, SER | ||||
| 166 | ALPHA-GLOBIN COMMON | ||||
| 167 | ALPHA-GLOBIN COMMONMUTAT | ||||
| 168 | ALRGN-BAYBERRY | ||||
| 169 | ALT | ||||
| 170 | ALTERNARIA TEN IGG | ||||
| 171 | ALUMINUM | ||||
| 172 | ALUMINUM, SERUM | ||||
| 173 | AMERICAN COCKROACH IGE** | ||||
| 174 | AMH, FEMALE | ||||
| 175 | AMH, FEMALE | ||||
| 176 | AMIKACIN | ||||
| 177 | AMIKACIN, SERUM | ||||
| 178 | AMIKACIN, TROUGH | ||||
| 179 | AMIODARONE | ||||
| 180 | AMIODARONE | ||||
| 181 | AMITRIPTYLINE | ||||
| 182 | AMITRIPTYLINE | ||||
| 183 | AMPHETAMINE BY GC/MS, UR | ||||
| 184 | AMPHETAMINE BY GCMS, SERU | ||||
| 185 | AMPHETAMINE CONFIRM, U8 | ||||
| 186 | AMPHETAMINES CONF URINE | ||||
| 187 | AMYLASE ISOENZYMES | ||||
| 188 | AMYLASE ISOENZYMES, SERUM | ||||
| 189 | AMYLASE, PANCREATIC CYST | ||||
| 190 | AMYLASE, PERITONEAL | ||||
| 191 | AMYLASE, PLEURAL | ||||
| 192 | AMYLASE, RAND UR W/CREAT | ||||
| 193 | AMYLOID A, IHC W/INTERP. | ||||
| 194 | ANA COMPREHENSIVE PANEL | ||||
| 195 | ANA IFA, WITH REFLEX TO | ||||
| 196 | ANA MUTLIPLEX W/RFL TO 11 | ||||
| 197 | ANA MUTLIPLEX W/RFL TO 11 | ||||
| 198 | ANA TITER & PATTERN | ||||
| 199 | ANA TITER & PATTERN | ||||
| 200 | ANA W/RFX | ||||
| 201 | ANA, TITER AND PATTERN | ||||
| 202 | ANA,IFA W/RFL TITR,PATTRN | ||||
| 203 | ANABOLIC STEROIDS SCRN, U | ||||
| 204 | ANAEROBE E-TEST PROFILE | ||||
| 205 | ANAEROBIC ID AND E TEST | ||||
| 206 | ANAPLASMA PHAGOCYTOPHILUM | ||||
| 207 | ANAPLASMA PHAGOCYTOPHILUM | ||||
| 208 | ANAPLASMA PHAGOCYTOPHILUM | ||||
| 209 | ANCA SCR W/RFL C,P,ATYPP | ||||
| 210 | ANCA SCR,MPO,PR3 W/RFL | ||||
| 211 | ANCA SCREEN W/ REFLEX TO | ||||
| 212 | ANCA SCRN W/MPO AND PR3 | ||||
| 213 | ANCA VASCULITIDES | ||||
| 214 | ANCA VASCULITIDES | ||||
| 215 | ANDROSTENEDIONE, LS/MS/MS | ||||
| 216 | ANDROSTENEDIONE,LC/MS/MS | ||||
| 217 | ANDROSTERONE, SERUM | ||||
| 218 | ANGIOTENSIN CONV ENZ | ||||
| 219 | ANGIOTENSIN CONV ENZ | ||||
| 220 | ANTI NEURONAL CELL AB | ||||
| 221 | ANTI NEURONAL CELL AB | ||||
| 222 | ANTI PM/SCL-100 AB | ||||
| 223 | ANTIBIOTIC SENSI TESTING | ||||
| 224 | ANTIBIOTIC SENSITIVITY | ||||
| 225 | ANTI-HMGCR AB (EIA) | ||||
| 226 | ANTI-HMGCR AB IGG | ||||
| 227 | ANTI-IBM ANTIBODY | ||||
| 228 | ANTI-ISLET CELL ANTIBODIE | ||||
| 229 | ANTIMICROB SUSC, AEROBIC | ||||
| 230 | ANTIMICROBIAL SUSC,AFB, | ||||
| 231 | ANTIMICROBIAL SUSC. NOCAR | ||||
| 232 | ANTIPHOSPHOLIPID AB PANEL | ||||
| 233 | ANTIPHOSPHOLIPID AB PANEL | ||||
| 234 | ANTI-STRIATED MUSCLE AB T | ||||
| 235 | ANTISTRIATED MUSCLE TITER | ||||
| 236 | ANTITHROMBIN III | ||||
| 237 | ANTITHROMBIN III ACTIVITY | ||||
| 238 | ANTI-THROMBIN III ANTIGEN | ||||
| 239 | ANTITHROMBIN III PROFILE | ||||
| 240 | ANTI-THYROGLOBULIN ANTIBO | ||||
| 241 | APC RESISTANCE | ||||
| 242 | APCR W/RFL FACTOR V LEIDN | ||||
| 243 | APOLIPOPROTEIN A1 | ||||
| 244 | APOLIPOPROTEIN B | ||||
| 245 | APOLIPOPROTEIN B | ||||
| 246 | APOLIPOPROTEIN B | ||||
| 247 | APPLE (F49) IGE | ||||
| 248 | APPLE (F49) IGE | ||||
| 249 | AQP4 (NMO IGG) | ||||
| 250 | AQUAPORIN 4 AB, CBA | ||||
| 251 | ARBOVIRUS AB PANEL,IFA SE | ||||
| 252 | ARBOVIRUS AB PNL, CSF | ||||
| 253 | ARSENIC, 24 HR URINE W/O | ||||
| 254 | ARSENIC, 24-HOUR URINE | ||||
| 255 | ARSENIC, 24-HR UR W/ | ||||
| 256 | ARSENIC, BLOOD | ||||
| 257 | ARSENIC, BLOOD | ||||
| 258 | ASCARIS (P1) IGE | ||||
| 259 | ASO AB | ||||
| 260 | ASPERGILLUS AG, EIA, BAL | ||||
| 261 | ASPERGILLUS AG,EIA,BAL | ||||
| 262 | ASPERGILLUS AG,EIA,SERUM | ||||
| 263 | ASPERGILLUS ANTIBODY | ||||
| 264 | ASPERGILLUS ANTIGEN | ||||
| 265 | ASPERGILLUS DNA, QL | ||||
| 266 | ASPERGILLUS FUMIGATUS IGG | ||||
| 267 | ATYPICAL P-ANCA TITE | ||||
| 268 | ATYPICAL P-ANCA TITER | ||||
| 269 | ATYPICAL P-ANCA TITER | ||||
| 270 | AUST PARROT FEATHERS IGE | ||||
| 271 | AVOCADO (F96) IGE | ||||
| 272 | AVOCADO (F96) IGE | ||||
| 273 | B HENSELAE IGG,M W/RFL | ||||
| 274 | B MICROTI AB (IGG, IGM) | ||||
| 275 | B. HENSELAE IGG TITER | ||||
| 276 | B. HENSELAE IGG TITER | ||||
| 277 | B. HENSELAE IGM TITER | ||||
| 278 | B. HENSELAE IGM TITER | ||||
| 279 | B. QUINTANA IGG TITER | ||||
| 280 | B2 MICROGLOBULIN W/CREAT | ||||
| 281 | B2 MICROGLOBULIN, SERUM | ||||
| 282 | B72.3 IHC W/O INTERP | ||||
| 283 | BABESIA MICROTI DNA RT | ||||
| 284 | BABESIA MICROTI DNA, PCR | ||||
| 285 | BABESIA MICROTI IGG,IGM | ||||
| 286 | BAC ID AND SUSC, AEROBIC | ||||
| 287 | BACTERIAL 16S RDNA | ||||
| 288 | BACTERIAL ID | ||||
| 289 | BACTERIAL ID AND SUSCEPT. | ||||
| 290 | BACTERIAL ID, AEROBIC | ||||
| 291 | BACTERIAL ID, ANAEROBIC | ||||
| 292 | BACTERIAL IDENTIFICATION | ||||
| 293 | BACTERIAL IDENTIFICATION, | ||||
| 294 | BACTERIAL VAGINOSIS/VAGIN | ||||
| 295 | BAHIA GRASS (G17) IGE | ||||
| 296 | BANANA (F92) IGE | ||||
| 297 | BANANA (F92) IGE | ||||
| 298 | BARBITURATES BY GC/MS UR | ||||
| 299 | BARBITURATES BY GC/MS, UR | ||||
| 300 | BARLEY (F6) IGE | ||||
| 301 | BARTONELLA HENSELAE (IGG | ||||
| 302 | BARTONELLA SPECIES AB | ||||
| 303 | BARTONELLASPECIESAB W/RFL | ||||
| 304 | BASIC METAB PNL | ||||
| 305 | B-CELL CLONALITY PANEL | ||||
| 306 | B-CELL CLONALITY, PCR | ||||
| 307 | BCL-2, IHC W/O INTERP | ||||
| 308 | BCL-2,IHC W/ INTERP | ||||
| 309 | BCL-6, IHC W/O INTERP | ||||
| 310 | BCL-6,IHC W/ INTERP | ||||
| 311 | BCR-ABL 35 NT INSERTION | ||||
| 312 | BCR-ABL1,QN PCR | ||||
| 313 | BEEF (F27) IGE | ||||
| 314 | BEEF (F27) IGE | ||||
| 315 | BENCE JONES PROTEIN PNL | ||||
| 316 | BENCE JONES PROTEIN, UR | ||||
| 317 | BENZODIAZEPINE, CONF,GCMS | ||||
| 318 | BENZODIAZEPINES, SERUM | ||||
| 319 | BEREP4,IHC W/O INTERP | ||||
| 320 | BERMUDA GRASS (G2) IGE | ||||
| 321 | BETA HCG, IHC W/O INTERP | ||||
| 322 | BETA-2 GLYCOPROTEIN 1 AB | ||||
| 323 | BETA-2 MICROGLOBULIN, SER | ||||
| 324 | BETA-2 MICROGLOBULIN, SER | ||||
| 325 | BETA-2 TRANSFERRIN | ||||
| 326 | BETA-2 TRANSFERRIN | ||||
| 327 | BETA2-GLYCOPROT I(G,A,M) | ||||
| 328 | BETA2-GLYCOPROTEIN (IGG) | ||||
| 329 | BETA2-GLYCOPROTEIN I ANTI | ||||
| 330 | BETA2-GLYCOPROTEIN I ANTI | ||||
| 331 | BETA2-GLYCOPROTEIN I IGG | ||||
| 332 | BETA-CATENIN, IHC W/O INT | ||||
| 333 | BETA-GLOBIN COMPLETE | ||||
| 334 | BICARBONATE, URINE | ||||
| 335 | BILE ACIDS, FRACTIONATED | ||||
| 336 | BIOTIN (B7) | ||||
| 337 | BK & JC VIRUS DNA, QL PCR | ||||
| 338 | BK VIRUS DNA, QN PCR | ||||
| 339 | BK VIRUS DNA, QUANT RT-PC | ||||
| 340 | BK VIRUS DNA,QN PCR,URINE | ||||
| 341 | BK VIRUS DNA,QUANT RT PCR | ||||
| 342 | BLACK PEPPER (F280) IGE | ||||
| 343 | BLACK PEPPER (F280) IGE | ||||
| 344 | BLADDER CANCER, FISH | ||||
| 345 | BLADDER CANCER, FISH | ||||
| 346 | BLASTOMYCES AB PANEL, CF | ||||
| 347 | BLASTOMYCES ANTIBODY,ID | ||||
| 348 | BLOOD SMEAR INTERP | ||||
| 349 | BLUEBERRY (RF288) IGE | ||||
| 350 | BM CORE IMPRINT | ||||
| 351 | BM INTERP,ASPIRATE SMEAR | ||||
| 352 | BM INTERP,CLOT/CELLBLK BX | ||||
| 353 | BM INTERP,CORE BIOPSY | ||||
| 354 | BMZ AB TITER | ||||
| 355 | BONE MARROW INTERP. | ||||
| 356 | BORDETELLA, CULTURE | ||||
| 357 | BP 180 ANTIBODY | ||||
| 358 | BP230 IGG | ||||
| 359 | BRAF MUTATION ANALYSIS | ||||
| 360 | BRAF MUTATION ANALYSIS | ||||
| 361 | BRAF MUTATION ANALYSIS | ||||
| 362 | BRAF, COBAS | ||||
| 363 | BRCAVANTAGE PLUS(R) | ||||
| 364 | BRCAVANTAGE,COMPREHENSIVE | ||||
| 365 | BROCCOLI (F260) IGE | ||||
| 366 | BROCCOLI (F260) IGE | ||||
| 367 | BRUCELLA AB(IGG,M) W/RFL | ||||
| 368 | BRUCELLA AB,AGGLUTINATION | ||||
| 369 | BRUCELLA AB,AGGLUTINATION | ||||
| 370 | BRUCELLA ABS (IGG,IGM) | ||||
| 371 | BULLOUS PEMPHIGOID AG | ||||
| 372 | BULLOUS PEMPHIGOID BP230 | ||||
| 373 | BUPRENORPHINE, QUANT, UR | ||||
| 374 | BUPROPION AND METABOLITE | ||||
| 375 | C PSITTACI AB (IGG,A,M) | ||||
| 376 | C. HERBARUM (M2) IGE | ||||
| 377 | C. TRACHOMATIS CULTURE | ||||
| 378 | C. TRACHOMATIS RNA, TMA | ||||
| 379 | C1 ESTERASE INHIBITOR | ||||
| 380 | C1 ESTERASE INHIBTR,FUNCT | ||||
| 381 | C1 INHIBITOR, FUNCTIONAL | ||||
| 382 | C1 INHIBITOR, PROTEIN | ||||
| 383 | C2 COMPLEMENT COMPONENT | ||||
| 384 | C2, SERUM | ||||
| 385 | C3 NEPHRITIC FACTOR | ||||
| 386 | C5, SERUM | ||||
| 387 | CA 125 | ||||
| 388 | CA 15-3 | ||||
| 389 | CA 15-3 | ||||
| 390 | CA 19-9 | ||||
| 391 | CA 19-9 | ||||
| 392 | CA 27.29 | ||||
| 393 | CA-125 | ||||
| 394 | CA27.29 | ||||
| 395 | CADMIUM, 24-HOUR URINE | ||||
| 396 | CADMIUM, BLOOD | ||||
| 397 | CADMIUM, BLOOD | ||||
| 398 | CALCITONIN | ||||
| 399 | CALCITONIN, SERUM | ||||
| 400 | CALCITONIN,IHC W/O INTERP | ||||
| 401 | CALCITONIN,IHC W/O INTERP | ||||
| 402 | CALCIUM, 24 HR U(W/CREAT) | ||||
| 403 | CALCIUM, IONIZED | ||||
| 404 | CALCIUM, IONIZED, SERUM | ||||
| 405 | CALCIUM,24-HOUR URINE | ||||
| 406 | CALCIUM,RANDOM UR W/CREAT | ||||
| 407 | CALPONIN, IHC W/O INTERP | ||||
| 408 | CALPONIN, IHC W/O INTERP | ||||
| 409 | CALPROTECTIN, STOOL | ||||
| 410 | CALPROTECTIN, STOOL | ||||
| 411 | CALRETICULIN (CALR) MUTAT | ||||
| 412 | CALRETICULIN (CALR) MUTAT | ||||
| 413 | CALRETININ,IHC W/O INTERP | ||||
| 414 | CAMPY CULTURE | ||||
| 415 | CAMPYLOBACTER JEJUNI AB, | ||||
| 416 | CAMPYLOBACTER,CULTURE | ||||
| 417 | C-ANCA TITER | ||||
| 418 | C-ANCA TITER | ||||
| 419 | C-ANCA TITER | ||||
| 420 | CANDIDA ALBICANS (M5) IGE | ||||
| 421 | CANDIDA ANTIBODY, ID | ||||
| 422 | CANDIDA IGG/IGM/IGA ABS | ||||
| 423 | CANNABINOIDS URINE W/RFL | ||||
| 424 | CARBOXYHEMOGLOBIN (B) | ||||
| 425 | CARBOXYHEMOGLOBIN, BLOOD | ||||
| 426 | CARDIO IQ (R) HS-CRP | ||||
| 427 | CARDIO IQ(R) ADV LIPID | ||||
| 428 | CARDIO IQ(R) HOMOCYSTEINE | ||||
| 429 | CARDIO IQ(R) LIPID PANEL | ||||
| 430 | CARDIO IQ(R) LIPOPROTEIN | ||||
| 431 | CARDIO IQ(R) LIPOPROTEIN | ||||
| 432 | CARDIO IQ(R) LP (A) | ||||
| 433 | CARDIOLIPIN AB (IGG) | ||||
| 434 | CARDIOLIPIN AB (IGG,A,M) | ||||
| 435 | CARDIOLIPIN AB, IGG IGM | ||||
| 436 | CARDIOLIPIN ANTIBODIES | ||||
| 437 | CARNITINE, LC/MS/MS | ||||
| 438 | CARNITINE, LC/MS/MS | ||||
| 439 | CAROTENE | ||||
| 440 | CAROTENE | ||||
| 441 | CARROT (F31) IGE | ||||
| 442 | CARROT (F31) IGE | ||||
| 443 | CASCADING REFLEX | ||||
| 444 | CASEIN (F78) IGE | ||||
| 445 | CASHEW NUT (F202) IGE | ||||
| 446 | CASHEW NUT (F202) IGE | ||||
| 447 | CASPR2 ANTIBODY TEST | ||||
| 448 | CAT DANDER (E1) IGE | ||||
| 449 | CAT DANDER (E1) IGE | ||||
| 450 | CATECHOL/VMA, 24H | ||||
| 451 | CATECHOLAMINES FRACT. 24- | ||||
| 452 | CATECHOLAMINES, 24 HR UR | ||||
| 453 | CATECHOLAMINES, PLASMA | ||||
| 454 | CATECHOLEMINES,FRACTION, | ||||
| 455 | CATHARTIC LAXATIVES PRF | ||||
| 456 | CBC (DIFF/PLT) | ||||
| 457 | CBC(H/H,RBC,WBC,PLT) | ||||
| 458 | CCP ANTIBODY (IGG) | ||||
| 459 | CD10,IHC W/ INTERP | ||||
| 460 | CD117,IHC W/ INTERP | ||||
| 461 | CD117-CKIT, IHC W/INTERP | ||||
| 462 | CD123, IHC WITHOUT INTERP | ||||
| 463 | CD138, IHC W/INTERP | ||||
| 464 | CD138,IHC W/ INTERP | ||||
| 465 | CD138,IHC W/O INTERP | ||||
| 466 | CD15,IHC W/O INTERP | ||||
| 467 | CD163, IHC W/ INTERP | ||||
| 468 | CD163, IHC W/O INTERP | ||||
| 469 | CD163, IHC WITHOUT INTERP | ||||
| 470 | CD19, B CELLS | ||||
| 471 | CD19, IHC WITHOUT INTERP. | ||||
| 472 | CD1A, IHC W/O INTERP | ||||
| 473 | CD2, IHC W/O INTERP. | ||||
| 474 | CD20,IHC W/ INTERP | ||||
| 475 | CD21, IHC W/ INTERP | ||||
| 476 | CD21, IHC W/O INTERP. | ||||
| 477 | CD23,IHC W/ INTERP | ||||
| 478 | CD25, IHC W/O INTERP | ||||
| 479 | CD3, IHC W/INTERPRETATION | ||||
| 480 | CD3,IHC W/ INTERP | ||||
| 481 | CD30, IHC W/INTERP | ||||
| 482 | CD30, IHC W/O INTERP | ||||
| 483 | CD30,IHC W/ INTERP | ||||
| 484 | CD31,IHC W/O INTERP | ||||
| 485 | CD34, IHC W/INTERP | ||||
| 486 | CD34,IHC W/ INTERP | ||||
| 487 | CD35, IHC W/O INTERP | ||||
| 488 | CD43,IHC W/O INTERP | ||||
| 489 | CD5,IHC W/ INTERP | ||||
| 490 | CD52,IHC W/O INTERP | ||||
| 491 | CD56, IHC W/O INTERP | ||||
| 492 | CD56,IHC W/ INTERP | ||||
| 493 | CD56,IHC W/O INTERP | ||||
| 494 | CD57, IHC W/O INTERP | ||||
| 495 | CD57,IHC W/ INTERP | ||||
| 496 | CD61, IHC W/INTERP | ||||
| 497 | CD61,IHC W/ INTERP | ||||
| 498 | CD68, IHC W/INTERP | ||||
| 499 | CD68,IHC W/ INTERP | ||||
| 500 | CD68,IHC W/O INTERP | ||||
| 501 | CD7, IHC W/O INTERP | ||||
| 502 | CD79A,IHC W/ INTERP | ||||
| 503 | CD79A,IHC W/O INTERP | ||||
| 504 | CDX2, IHC WITH INTERP. | ||||
| 505 | CEA POLY, IHC W/O INTERP | ||||
| 506 | CEA, PANCREATIC CYST FLUI | ||||
| 507 | CEA, PLEURAL | ||||
| 508 | CEA,MONO,IHC W/O INTERP | ||||
| 509 | CEA,PANCREATIC CYST FLUID | ||||
| 510 | CEA,POLYCLONAL W/O INTERP | ||||
| 511 | CEBPA MUTATION ANALYSIS | ||||
| 512 | CEBPA MUTATION ANALYSIS | ||||
| 513 | CELIAC DISEASE COMP PANEL | ||||
| 514 | CELIAC DISEASE COMPRE | ||||
| 515 | CELIAC DISEASE COMPREHENS | ||||
| 516 | CELIAC DISEASE PNL W/GLI | ||||
| 517 | CELL CT AND DIFF,CSF | ||||
| 518 | CENTROMERE B ANTIBODY | ||||
| 519 | CENTROMERE B ANTIBODY | ||||
| 520 | CENTROMERE B ANTIBODY | ||||
| 521 | CERULOPLASMIN | ||||
| 522 | CERULOPLASMIN | ||||
| 523 | CF, INTRON 8 POLY-T | ||||
| 524 | CFVANTAGE(TM) CF EXPANDED | ||||
| 525 | CHEESE MOLD TYPE (F82) | ||||
| 526 | CHEK2 SEQ,DEL,DUP | ||||
| 527 | CHERRY (F242) IGE | ||||
| 528 | CHERRY (F242) IGE | ||||
| 529 | CHICKEN MEAT (F83) IGE | ||||
| 530 | CHICKEN MEAT (F83) IGE | ||||
| 531 | CHIKUNGUNYA ANTIBODIES | ||||
| 532 | CHIKUNGUNYA VIRUS RNA,QL | ||||
| 533 | CHILI PEPPER (RF279) IGE | ||||
| 534 | CHLAMYD/GC RNA,TMA,RECTL | ||||
| 535 | CHLAMYD/GC RNA,TMA,THROTC | ||||
| 536 | CHLAMYDIA CHLAMYDOPHILA 3 | ||||
| 537 | CHLAMYDIA TRACHOMATIS /N. | ||||
| 538 | CHLAMYDIA TRACHOMATIS CUL | ||||
| 539 | CHLAMYDIA TRACHOMATIS RNA | ||||
| 540 | CHLAMYDIA/CHLAMYDOPHILA | ||||
| 541 | CHLAMYDIA/GC, RNA, TMA | ||||
| 542 | CHLAMYDIA-GC, TMA, THROAT | ||||
| 543 | CHLAMYDOPHILA PSITTACI AB | ||||
| 544 | CHOCOLATE (F93) IGE | ||||
| 545 | CHOL, PL FLUID | ||||
| 546 | CHOLESTEROL, PLEURAL | ||||
| 547 | CHOLESTEROL, TOTAL | ||||
| 548 | CHOLINESTERASE, RBC, P | ||||
| 549 | CHOLINESTERASE, SERUM | ||||
| 550 | CHOLINESTERASE, SERUM | ||||
| 551 | CHOLINESTERASE,DIBUCAINE | ||||
| 552 | CHROMIUM SERUM | ||||
| 553 | CHROMIUM, BLOOD | ||||
| 554 | CHROMIUM, PLASMA | ||||
| 555 | CHROMIUM, PLASMA | ||||
| 556 | CHROMIUM, SERUM | ||||
| 557 | CHROMIUM,BLOOD | ||||
| 558 | CHROMOGRANIN A | ||||
| 559 | CHROMOGRANIN A, ECL | ||||
| 560 | CHROMOSOME ANALYSIS BLOOD | ||||
| 561 | CHROMOSOME ANALYSIS, HEMA | ||||
| 562 | CHROMOSOME, HEMATOLOGIC | ||||
| 563 | CHROMOSOMES, BLOOD | ||||
| 564 | CHRONIC URTICARIA PANEL | ||||
| 565 | CHRONIC URTICARIA PANEL | ||||
| 566 | CHRONIC URTICARIA PNL 2 | ||||
| 567 | CITRIC ACID 24-HR URINE | ||||
| 568 | CITRIC ACID 24U W/O CREAT | ||||
| 569 | CITRIC ACID,24H U W/CREAT | ||||
| 570 | CK ISOENZYMES | ||||
| 571 | CK, TOTAL | ||||
| 572 | C-KIT MUTATION ANALYSIS, | ||||
| 573 | C-KIT MUTATION,CELL-BASED | ||||
| 574 | C-KIT W/RFL PDGFRA | ||||
| 575 | CLAM (F207) IGE | ||||
| 576 | CLAM (F207) IGE | ||||
| 577 | CLL IGVH MUTATION,CELL | ||||
| 578 | CLL PROGN, COMP W/O KARYO | ||||
| 579 | CLL PROGNOSTIC PNL,COMP | ||||
| 580 | CLL, IGVH MUTATION STATUS | ||||
| 581 | CLOMIPRAMINE | ||||
| 582 | CLOMIPRAMINE | ||||
| 583 | CLONAZEPAM | ||||
| 584 | CLONAZEPAM & METAB CNF | ||||
| 585 | CLONAZEPAM & METAB SCR | ||||
| 586 | CLONAZEPAM (KLONOPIN) | ||||
| 587 | CLOSTRIDIUM DIFF. TOXIN B | ||||
| 588 | CLOZAPINE | ||||
| 589 | CLOZAPINE | ||||
| 590 | CMV AB (IGG) | ||||
| 591 | CMV AB (IGG, IGM) | ||||
| 592 | CMV AB (IGM) | ||||
| 593 | CMV ANTIBODY (IGG) | ||||
| 594 | CMV CULTURE | ||||
| 595 | CMV DNA, QN PCR | ||||
| 596 | CMV DNA,QL PCR | ||||
| 597 | CMV IHC W/INTERP | ||||
| 598 | CMV IHC W/INTERP~2 | ||||
| 599 | CMV IHC W/O INTERP | ||||
| 600 | CMV,IHC W/O INTERP | ||||
| 601 | CNBP DNA TEST (DM2) | ||||
| 602 | COBALT, BLOOD | ||||
| 603 | COBALT, BLOOD | ||||
| 604 | COCAINE CONFIRMATION GCMS | ||||
| 605 | COCAINE METABOLITES GC/MS | ||||
| 606 | COCCIDIOIDES AB TO TP AND | ||||
| 607 | COCCIDIOIDES AB, CF | ||||
| 608 | COCCIDIOIDES AB, CF | ||||
| 609 | COCCIDIOIDES AB,CF AND ID | ||||
| 610 | COCCIDIOIDES AB,CF,SERUM | ||||
| 611 | COCCIDIOIDES AB,ID | ||||
| 612 | COCCIDIOIDES ABS TP & F | ||||
| 613 | COCKROACH (I6) IGE | ||||
| 614 | COCOA (F93) IGE | ||||
| 615 | COCONUT (F36) IGE | ||||
| 616 | CODFISH (F3) IGE | ||||
| 617 | CODFISH (F3) IGE | ||||
| 618 | COENZYME Q10 | ||||
| 619 | COENZYME Q10 | ||||
| 620 | COENZYME Q10 | ||||
| 621 | COLD AGGLUTININS | ||||
| 622 | COLD HEMAGGLUTININS | ||||
| 623 | COLLAGEN CROSS-LINK N-TEL | ||||
| 624 | COLLAGEN CROSS-LINKED | ||||
| 625 | COLLAGEN TYPE I C-TELOPEP | ||||
| 626 | COLORECTAL CANCER MUT | ||||
| 627 | COLORECTL CANCRMUTATN PNL | ||||
| 628 | COMMON RAGWEED (W1) IGE | ||||
| 629 | COMP METAB PNL | ||||
| 630 | COMP. VIRUS CULTURE | ||||
| 631 | COMPLEMENT COMP C3 AND C4 | ||||
| 632 | COMPLEMENT COMPONENT C1Q | ||||
| 633 | COMPLEMENT COMPONENT C1Q | ||||
| 634 | COMPLEMENT, TOTAL (CH50) | ||||
| 635 | COMPLEMENT,TOTAL (CH50) | ||||
| 636 | COMPREHENSIVE KIDNEY PNL | ||||
| 637 | CONCENTRATION | ||||
| 638 | CONGO RED AMYLOID STAIN | ||||
| 639 | COPEPTIN | ||||
| 640 | COPEPTIN | ||||
| 641 | COPPER | ||||
| 642 | COPPER | ||||
| 643 | COPPER | ||||
| 644 | COPPER, 24 HR URINE | ||||
| 645 | COPPER, 24-HOUR URINE | ||||
| 646 | COPPER, BLOOD | ||||
| 647 | COPPER, LIVER TISSUE | ||||
| 648 | COPPER, RANDOM URINE | ||||
| 649 | COPPER, URINE W/CREAT | ||||
| 650 | CORN (F8) IGE | ||||
| 651 | CORTISOL FREE, 24HR URINE | ||||
| 652 | CORTISOL, FREE, URINE | ||||
| 653 | CORTISOL, LC/MS/MS, SALIV | ||||
| 654 | CORTISOL, LC/MS/MS, SALX3 | ||||
| 655 | CORTISOL, LC/MS/MS,SALIVA | ||||
| 656 | CORTISOL,FREE&CORTISONE | ||||
| 657 | COUMADIN | ||||
| 658 | COW'S MILK (F2) IGE | ||||
| 659 | COW'S MILK (F2) IGE | ||||
| 660 | COXSACKIE A AB PANEL-SER | ||||
| 661 | COXSACKIE A ANTIBODY | ||||
| 662 | COXSACKIE B (1-6) AB,S | ||||
| 663 | COXSACKIE B (1-6) ANTIBOD | ||||
| 664 | C-PEPTIDE | ||||
| 665 | C-PEPTIDE | ||||
| 666 | CRAB (F23) IGE | ||||
| 667 | CRAB (F23) IGE | ||||
| 668 | CREATINE KINASE(CK) ISOEN | ||||
| 669 | CREATINE, 24 HR URINE | ||||
| 670 | CREATININE | ||||
| 671 | CREATININE, 24 HR URINE | ||||
| 672 | CREATININE, URINE | ||||
| 673 | CRP | ||||
| 674 | CRYOFIBRINOGEN | ||||
| 675 | CRYOFIBRINOGEN | ||||
| 676 | CRYOGLOBULIN REFLEX | ||||
| 677 | CRYOGLOBULIN REFLEX | ||||
| 678 | CRYOGLOBULIN SCREEN | ||||
| 679 | CRYOGLOBULIN SCREEN/RFLX | ||||
| 680 | CRYOGLOBULIN, SERUM | ||||
| 681 | CRYPTOCOCCAL AG SCR W/RFL | ||||
| 682 | CRYPTOCOCCAL AG, TITER | ||||
| 683 | CRYPTOCOCCAL ANTIGEN | ||||
| 684 | CRYPTOCOCCAL ANTIGEN | ||||
| 685 | CRYPTOCOCCUS AB | ||||
| 686 | CRYPTOCOCCUS ANTIBODIES | ||||
| 687 | CRYPTOCOCCUS ANTIBODY | ||||
| 688 | CSF, VDRL | ||||
| 689 | CSF3R MUTATION ANALYSIS | ||||
| 690 | CT,DIFF SYNOVIAL FL | ||||
| 691 | CT/NG,TMA | ||||
| 692 | C-TELOPEPTIDE (CTX) | ||||
| 693 | CUCUMBER (F244) IGE | ||||
| 694 | CULT WHEATPOLLEN(G15) IGE | ||||
| 695 | CULT, (U) ROUTINE | ||||
| 696 | CULTURE FUNGUS S/H/N | ||||
| 697 | CULTURE FUNGUS, MISC. | ||||
| 698 | CULTURE, FUNGUS, BLOOD | ||||
| 699 | CULTURE, FUNGUS, SKIN, | ||||
| 700 | CULTURE, SEMEN | ||||
| 701 | CULTURE, VARICELLA-ZOSTER | ||||
| 702 | CULTURE, VIRAL | ||||
| 703 | CULTURE,STOOL,SHIGA W/RFL | ||||
| 704 | CUSTOM REGIONAL PANEL | ||||
| 705 | CUTANEOUS DIRECT IMMUN~2 | ||||
| 706 | CUTANEOUS DIRECT IMMUNOFL | ||||
| 707 | CYCLIC CITRULLINATED | ||||
| 708 | CYCLIN D1,IHC W/ INTERP | ||||
| 709 | CYCLOSPORA AND ISOSPORA | ||||
| 710 | CYCLOSPORA/ISOSPORA EXAM | ||||
| 711 | CYCLOSPORINE A TROUGH, | ||||
| 712 | CYCLOSPORINE A TROUGH,BLO | ||||
| 713 | CYCLOSPORINE A,TROUGH,B | ||||
| 714 | CYCLOSPORINE,TROUGHLCMSMS | ||||
| 715 | CYSTATIN C W/EGFR | ||||
| 716 | CYSTATIN C W/EGFR | ||||
| 717 | CYSTATIN C WITH GLOMERULA | ||||
| 718 | CYSTIC FIBROSIS SCREEN | ||||
| 719 | CYSTIC FIBROSIS SCREEN | ||||
| 720 | CYSTINE, 24 HR URINE | ||||
| 721 | CYSTINE, 24-HOUR URINE | ||||
| 722 | CYTO, NON-GYN, LIQ PREP 1 | ||||
| 723 | CYTOKER 19,W/O INTERP | ||||
| 724 | CYTOKER AE1/AE3,W/ INTERP | ||||
| 725 | CYTOKERAE1/AE3,W/O INTERP | ||||
| 726 | CYTOKERATIN 18, IHC W/O I | ||||
| 727 | CYTOKERATIN 19, IHC W/O I | ||||
| 728 | CYTOKERATIN 20, IHC W/INT | ||||
| 729 | CYTOKERATIN 7, IHC W/INTE | ||||
| 730 | CYTOKERATIN 8 & 18 W/O IN | ||||
| 731 | CYTOKERATIN AE1/AE3 W/O I | ||||
| 732 | CYTOMEGALOVIRUS ABS | ||||
| 733 | CYTOMEGALOVIRUS ANTIBODIE | ||||
| 734 | CYTOMEGALOVIRUS CULTURE | ||||
| 735 | CYTOMEGALOVIRUS DNA,QL | ||||
| 736 | CYTOMEGALOVIRUS DNA,QUAL | ||||
| 737 | CYTOMEGALOVIRUS DNA,QUANT | ||||
| 738 | D. FARINAE (D2) IGE | ||||
| 739 | D. PTERONYSSINUS (D1) IGE | ||||
| 740 | D2-40, IHC WITHOUT INTERP | ||||
| 741 | DECALCIFICATION | ||||
| 742 | DECALCIFICATION | ||||
| 743 | DELTA ALA, 24 HR URINE | ||||
| 744 | DENGUE FEVER (IGG,M) | ||||
| 745 | DENGUE FEVER AB (IGG,IGM) | ||||
| 746 | DEOXYCORTICOSTERON,LCMSMS | ||||
| 747 | DESIPRAMINE | ||||
| 748 | DESIPRAMINE | ||||
| 749 | DESMOGLEIN ANTIBODIES | ||||
| 750 | DESMOGLEIN ANTIBODIES | ||||
| 751 | DEXAMETHASONE | ||||
| 752 | DEXAMETHASONE | ||||
| 753 | DEXAMETHASONE SUPPRESSION | ||||
| 754 | DHEA (DEHYDROEPIANDROSTER | ||||
| 755 | DHEA SULFATE | ||||
| 756 | DHEA SULFATE | ||||
| 757 | DHEA,UNCONJUGATD,LC/MS/MS | ||||
| 758 | DHT LCMSMS | ||||
| 759 | DIAGNOSTIC CONSULTATION | ||||
| 760 | DIAZEPAM AND METABOLITE | ||||
| 761 | DIAZEPAM AND METABOLITE | ||||
| 762 | DIHYDROTESTOSTERON,LCMSMS | ||||
| 763 | DIPHENHYDRAMINE, SER/PLA | ||||
| 764 | DIPHTHERIA AND TETANUS | ||||
| 765 | DIPHTHERIA AND TETANUS | ||||
| 766 | DIPHTHERIA AND TETANUS | ||||
| 767 | DIPHTHERIA ANTITOXOID | ||||
| 768 | DIPHTHERIA ANTITOXOID | ||||
| 769 | DIPHTHERIA ANTITOXOID | ||||
| 770 | DIURETICS SCREEN, URINE | ||||
| 771 | D-LACTATE, PLASMA | ||||
| 772 | DM SYN STIM QN,U | ||||
| 773 | DM SYNTH CANNAB | ||||
| 774 | DM SYNTH CANNAB | ||||
| 775 | DNA (DS) ANTIBODY | ||||
| 776 | DNA (DS) ANTIBODY | ||||
| 777 | DNA (DS) ANTIBODY | ||||
| 778 | DNA (DS) ANTIBODY | ||||
| 779 | DNA (DS) ANTIBODY | ||||
| 780 | DNA (DS) ANTIBODY, HIGH | ||||
| 781 | DNA(DS) AB, RIA | ||||
| 782 | DNA(DS) AB,CRITHIFA W/RFL | ||||
| 783 | DNA(DS)TITER | ||||
| 784 | DOG DANDER (E5) IGE | ||||
| 785 | DOG DANDER (E5) IGE | ||||
| 786 | DOG1, IHC W/O INTERP | ||||
| 787 | DOXEPIN | ||||
| 788 | DRAW FEE, PSC SPEC. | ||||
| 789 | DRUG ABUSE PANEL 9, SERUM | ||||
| 790 | DRUG ABUSE SCREEN 7, S | ||||
| 791 | DRUG TEST,GENRL TOX,S/P | ||||
| 792 | DRUG TEST,GENRL TOX,U | ||||
| 793 | DRVVT 1:1 MIX | ||||
| 794 | DRVVT 1:1 MIX | ||||
| 795 | DRVVT 1:1 MIX | ||||
| 796 | DRVVT CONFIRM | ||||
| 797 | DRVVT CONFIRM | ||||
| 798 | DRVVT CONFIRM | ||||
| 799 | DRVVT CONFIRMATION | ||||
| 800 | DRVVT SCREEN WITH REFLEX | ||||
| 801 | DSDNA AB, IFA, TITER | ||||
| 802 | DS-DNA ANTIBODY CRITHIDIA | ||||
| 803 | DTM ORAL FL TEST 12 | ||||
| 804 | EARLY SJOGRENS SYN | ||||
| 805 | EAST. EQUINE ENCEPH. | ||||
| 806 | EBV DNA QUAL. PCR | ||||
| 807 | EBV DNA, QL PCR | ||||
| 808 | EBV DNA, QN PCR | ||||
| 809 | EBV DNA, QN PCR | ||||
| 810 | EBV ISH W/O INTERP | ||||
| 811 | EBV, ISH WITH INTERP. | ||||
| 812 | EBV,ISH W/INTERP | ||||
| 813 | EBV,ISH W/O INTERP | ||||
| 814 | E-CADHERIN, IHC W/O INTER | ||||
| 815 | E-CADHERIN,IHC W/INTERP | ||||
| 816 | E-CADHERIN,IHC W/O INTERP | ||||
| 817 | ECHINOCOCCUS AB IGG WITH | ||||
| 818 | ECHINOCOCCUS IGG W/RFL WB | ||||
| 819 | ECHOVIRUS AB, SERUM | ||||
| 820 | EGFR MUT SOLID TUMOR | ||||
| 821 | EGFR MUTATION | ||||
| 822 | EGG MIX (F245) IGE | ||||
| 823 | EGG WHITE (F1) IGE | ||||
| 824 | EGG YOLK (F75) IGE | ||||
| 825 | EHRLICHIA CHAFFEENSIS ANT | ||||
| 826 | ELECTROLYTES, FECES | ||||
| 827 | ELECTROLYTES, FECES | ||||
| 828 | ELECTROLYTES, FECES | ||||
| 829 | ELECTROPHORESIS, PROTEIN | ||||
| 830 | ENCEPH AB EVAL W/RFL,CSF | ||||
| 831 | ENCEPHALITIS AB PNL CSF | ||||
| 832 | ENDOMYSIAL AB SCR | ||||
| 833 | ENDOMYSIAL AB SCR W/REFL | ||||
| 834 | ENDOMYSIAL AB SCREEN (IGA | ||||
| 835 | ENDOMYSIAL AB TITER | ||||
| 836 | ENDOMYSIAL AB TITER | ||||
| 837 | ENDOMYSIAL ANTIBODY SCRN. | ||||
| 838 | ENDOMYSIAL ANTIBODY TITER | ||||
| 839 | ENTAMOEBA HIST. IGG, ELIS | ||||
| 840 | ENTEROVIRUS CULTURE | ||||
| 841 | ENTEROVIRUS PANEL, CF, | ||||
| 842 | ENTEROVIRUS RNA, RT-PCR | ||||
| 843 | ENVIROMENTAL ALLERGENS | ||||
| 844 | ENVIRONMENTAL ALLERGENS | ||||
| 845 | EOSINOPHIL COUNT (U) | ||||
| 846 | EPIDERMAL AB W/TITER | ||||
| 847 | EPIDERMAL GROWTH FACTOR | ||||
| 848 | EPINEPHRINE, PLASMA | ||||
| 849 | EPSTEIN BARR VIRUS AB PNL | ||||
| 850 | EPSTEIN BARR VIRUS, DNA | ||||
| 851 | EPSTEIN BARR VIRUS, DNA | ||||
| 852 | EPSTEIN-BARR VIRUS ANTIBO | ||||
| 853 | EPSTEIN-BARR VIRUS, EARLY | ||||
| 854 | ER IHC W/O INTERP | ||||
| 855 | ER, IHC W/INTERP | ||||
| 856 | ER,IHC W/ INTERPRETATION | ||||
| 857 | ER,IHC W/O INTERPRETATION | ||||
| 858 | ER/PR, PARAFFIN BLOCK | ||||
| 859 | ER/PR, PARAFFIN BLOCK | ||||
| 860 | ER/PR/HER W/RFL TO FISH | ||||
| 861 | ER/PR/HER2 W/REFLEX HER2 | ||||
| 862 | ERG, IHC W/INTERP | ||||
| 863 | ERG, IHC W/O INTERP | ||||
| 864 | ERYTHROPOIETIN | ||||
| 865 | ERYTHROPOIETIN(EPO) | ||||
| 866 | ESTRADIOL ULTRA SENSITIVE | ||||
| 867 | ESTRADIOL,EXTRACTION | ||||
| 868 | ESTRIOL, LC/MS/MS, SERUM | ||||
| 869 | ESTROGENS, FRACTIONATED | ||||
| 870 | ESTROGENS, TOTAL | ||||
| 871 | ESTROGENS, TOTAL, SERUM | ||||
| 872 | ESTRONE, LC/MS/MS | ||||
| 873 | ESTRONE, LC/MS/MS | ||||
| 874 | E-TEST MIC;S.A.17649 | ||||
| 875 | ETG/ETS CONFIRMATION | ||||
| 876 | ETHOSUXIMIDE | ||||
| 877 | ETHYLENE GLYCOL, BLOOD | ||||
| 878 | ETHYLENE GLYCOL, S/B/P | ||||
| 879 | EVEROLIMUS, BLOOD | ||||
| 880 | EVEROLIMUS, BLOOD | ||||
| 881 | FACTOR 13A W/O INTERP | ||||
| 882 | FACTOR II ACTIVITY | ||||
| 883 | FACTOR II ACTIVITY, CLOTT | ||||
| 884 | FACTOR IX ACT & INHIBITOR | ||||
| 885 | FACTOR IX ACTIVITY | ||||
| 886 | FACTOR IX ACTIVITY, CLOTT | ||||
| 887 | FACTOR V (LEIDEN)MUTATION | ||||
| 888 | FACTOR V ACTIVITY | ||||
| 889 | FACTOR V ACTIVITY, CLOTTI | ||||
| 890 | FACTOR V(LEIDEN)MUTATION | ||||
| 891 | FACTOR VII ACTIVITY | ||||
| 892 | FACTOR VII ACTIVITY, CLOT | ||||
| 893 | FACTOR VIII ACTIVITY, | ||||
| 894 | FACTOR VIII ACTIVITY,CL | ||||
| 895 | FACTOR VIII ACTIVITY,CLOT | ||||
| 896 | FACTOR VIII INHIBITOR PNL | ||||
| 897 | FACTOR VIII INHIBITOR PNL | ||||
| 898 | FACTOR X ACTIVITY | ||||
| 899 | FACTOR X ACTIVITY, | ||||
| 900 | FACTOR X ACTIVITY, CLOTTI | ||||
| 901 | FACTOR XI | ||||
| 902 | FACTOR XI ACTIVITY, CLOTT | ||||
| 903 | FACTOR XII ACTIVITY | ||||
| 904 | FACTOR XII ACTIVITY, CLOT | ||||
| 905 | FACTOR XIII, FUNCTIONAL | ||||
| 906 | FACTOR13A, IHC W/O INTERP | ||||
| 907 | FAMILIAL HYPOCALCIURIC | ||||
| 908 | FATTY ACID PNL,ESS | ||||
| 909 | FATTY ACIDS, FECAL TOTAL | ||||
| 910 | FECAL FAT, QUAL | ||||
| 911 | FECAL FAT, QUAL | ||||
| 912 | FECAL FAT, QUALITATIVE | ||||
| 913 | FECAL LEUKOCYTE STN | ||||
| 914 | FECAL LIPIDS, TOTAL | ||||
| 915 | FENTANYL AND NORFENTANYL | ||||
| 916 | FENTANYL AND NORFENTANYL, | ||||
| 917 | FENTANYL PRESUMP. SCRN UR | ||||
| 918 | FERRITIN | ||||
| 919 | FETAL HEMOGLOBIN | ||||
| 920 | FGF-23 | ||||
| 921 | FGF-23 (FIBROBLAST GROWTH | ||||
| 922 | FH PANEL | ||||
| 923 | FIBRILLARIN (U3 RNP) | ||||
| 924 | FILARIA AB (IGG4) | ||||
| 925 | FIRE ANT (I70) IGE | ||||
| 926 | FIRE ANT (I70) IGE | ||||
| 927 | FISH AML1/ETO T 8;21 | ||||
| 928 | FISH DEL 13Q | ||||
| 929 | FISH FOLLICULAR LYMPHOMA, | ||||
| 930 | FISH, 1Q21 | ||||
| 931 | FISH, ALL, PRE-B | ||||
| 932 | FISH, AML M3, PML/RARA, T | ||||
| 933 | FISH, AML M4, CBFB/MYH11 | ||||
| 934 | FISH, B-CELL CHRONIC | ||||
| 935 | FISH, B-CELL MALIGNANCY | ||||
| 936 | FISH, BURKITT, T(8;14) | ||||
| 937 | FISH, BURKITT, T(8;14) | ||||
| 938 | FISH, BURKITT'S/NHL/ALL | ||||
| 939 | FISH, CLL, ATM DEL | ||||
| 940 | FISH, CML/ALL BCR/ABL | ||||
| 941 | FISH, EWING/PNET, EWSR1 | ||||
| 942 | FISH, FGFR1, 8P11-12 | ||||
| 943 | FISH, FOLLICULAR LYMPHOMA | ||||
| 944 | FISH, HER-2/NEU | ||||
| 945 | FISH, HER-2/NEU,PARAF | ||||
| 946 | FISH, HES/LEUKEMIA | ||||
| 947 | FISH, HIGH-GRADE LYMPHOMA | ||||
| 948 | FISH, LOCUS-SPECIFIC PROB | ||||
| 949 | FISH, LOCUSSPECIFIC(1) | ||||
| 950 | FISH, LOCUSSPECIFIC(2) | ||||
| 951 | FISH, LOCUSSPECIFIC(3) | ||||
| 952 | FISH, MALT LYMPH,REA18Q21 | ||||
| 953 | FISH, MALT LYMPH,REA18Q21 | ||||
| 954 | FISH, MALT LYMPH,T(11;18) | ||||
| 955 | FISH, MDS PANEL | ||||
| 956 | FISH, MECOM (EVI1),3Q26.2 | ||||
| 957 | FISH, MET AMPLIFICATION | ||||
| 958 | FISH, MPN (EOSINOPHILIA) | ||||
| 959 | FISH, MULTIPLE MYELOMA | ||||
| 960 | FISH, MYC-BA, 8Q24 | ||||
| 961 | FISH, MYELOMA W/REFLEXES | ||||
| 962 | FISH, MYELOMA, CHROMOSOME | ||||
| 963 | FISH, MYELOMA, IGH PANEL | ||||
| 964 | FISH, MYELOMA, IGH PANEL | ||||
| 965 | FISH, MYELOMA, T(14;16) | ||||
| 966 | FISH, NHL, BCL6 | ||||
| 967 | FISH, P53 | ||||
| 968 | FISH, PDGFRB, 5Q33.1 | ||||
| 969 | FISH, T CELL RECEPTOR | ||||
| 970 | FISH, TCL1, 14Q32.1 | ||||
| 971 | FISH, TCL1, 14Q32.1 | ||||
| 972 | FISH,AML M3,PML/RARA | ||||
| 973 | FISH,AML M3,PML/RARA | ||||
| 974 | FISH,AML/MDS,-7/DE | ||||
| 975 | FISH,B-CELL MALIGNANCY | ||||
| 976 | FISH,CML/ALL,BCR/ABL TRAN | ||||
| 977 | FISH,HER-2/NEU W/RFL IHC | ||||
| 978 | FISH,MALT LYMPH,REQ18Q21 | ||||
| 979 | FISH,MALT REA18Q21 W/RFL | ||||
| 980 | FISH,MANTLE CELL LYMPHOMA | ||||
| 981 | FISH,MANTLE CELL LYMPHOMA | ||||
| 982 | FISH,MDS/MYELOID PNL | ||||
| 983 | FISH,MLL,11Q23 REARRANGE | ||||
| 984 | FISH,MPN (EOSINOPHILIA) | ||||
| 985 | FISH,MYELOMA,17P-,REA 14Q | ||||
| 986 | FISH,MYELOMA,T(14;16) | ||||
| 987 | FISH,NHL,BCL6 3Q27 REA | ||||
| 988 | FISH-B-CELL CLL PNL | ||||
| 989 | FLECAINIDE | ||||
| 990 | FLECAINIDE (TAMBOCOR TM) | ||||
| 991 | FLT3 ITD AND TKD MUTATION | ||||
| 992 | FLT3 ITD AND TKD MUTATION | ||||
| 993 | FLUCYTOSINE, SERUM/PLASMA | ||||
| 994 | FLUOXETINE | ||||
| 995 | FLUOXETINE | ||||
| 996 | FOLATE, RBC | ||||
| 997 | FOLATE, RBC | ||||
| 998 | FOLATE,SERUM | ||||
| 999 | FOOD ALLERGY PROFILE | ||||
| 1000 | FOOD ALLERGY PROFILE, | ||||
| 1001 | FRAC. CATECHOLAMINES W/CR | ||||
| 1002 | FRANCISELLA TULARENSIS AB | ||||
| 1003 | FRANCISELLA TULARENSIS AB | ||||
| 1004 | FREE PHENYTOIN | ||||
| 1005 | FRONTOTEMPORAL DEMENTIA | ||||
| 1006 | FRUCTOSAMINE | ||||
| 1007 | FRUCTOSAMINE | ||||
| 1008 | FTA, CONFIRMATORY TESTING | ||||
| 1009 | FTA-ABS | ||||
| 1010 | FTA-ABS | ||||
| 1011 | FUNGAL AB PANEL, SERUM | ||||
| 1012 | FUNGAL CUL,HAIR,SKIN,NAIL | ||||
| 1013 | FUNGAL ID (MOLD) | ||||
| 1014 | FUNGAL ID MOLD | ||||
| 1015 | FUNGAL SEQUENCING, | ||||
| 1016 | FUNGAL STAIN, CALCOFLUOR, | ||||
| 1017 | FUNGITELL (R)(1-3)-B-D | ||||
| 1018 | FUNGITELL(R) (1-3) | ||||
| 1019 | FUNGUS CULTURE, MISC. | ||||
| 1020 | FUNGUS SMEAR | ||||
| 1021 | G-6-PD, QN | ||||
| 1022 | G-6-PD.QUANT. | ||||
| 1023 | GABAPENTIN | ||||
| 1024 | GABAPENTIN | ||||
| 1025 | GAD-65 AB | ||||
| 1026 | GAD-65 ANTIBODY | ||||
| 1027 | GAD65 NEURO SYND AB | ||||
| 1028 | GAD65,1A-2, & INSULIN | ||||
| 1029 | GAD65,1A-2, & INSULIN | ||||
| 1030 | GALACTOSE-ALPHA1,3-GALACT | ||||
| 1031 | GANGLIONIC NACHR AB TEST | ||||
| 1032 | GARLIC (F47) IGE | ||||
| 1033 | GARLIC (F47) IGE | ||||
| 1034 | GASTRIC PARIETAL CELL AB | ||||
| 1035 | GASTRIC PARIETAL CELL AB | ||||
| 1036 | GASTRIN | ||||
| 1037 | GASTRIN, IHC W/O INTERP | ||||
| 1038 | GASTRIN, RIA | ||||
| 1039 | GBM AB | ||||
| 1040 | GCDFP-15 IHC W/O INTERP | ||||
| 1041 | GEN TOX LCMSMS SP | ||||
| 1042 | GEN TOX URINE | ||||
| 1043 | GENOTYPE/PHENOTYPE REVIEW | ||||
| 1044 | GFAP, IHC W/O INTERP | ||||
| 1045 | GIARDIA AG, EIA, STOOL | ||||
| 1046 | GIARDIA ANTIBODY, IFA | ||||
| 1047 | GIARDIA ANTIGEN, EIA | ||||
| 1048 | GLIADIN ANTIBODY (IGG,IGA | ||||
| 1049 | GLIADIN(DEAMID)AB,IGG,IGA | ||||
| 1050 | GLIADIN(DEAMIDATED)AB,IGA | ||||
| 1051 | GLIADIN(DEAMIDATED)AB,IGG | ||||
| 1052 | GLIADIN(DEAMIDATED)AB,IGG | ||||
| 1053 | GLOMERULAR BASEMENT | ||||
| 1054 | GLUCAGON | ||||
| 1055 | GLUCAGON | ||||
| 1056 | GLUCAGON, PLASMA | ||||
| 1057 | GLUCAGON, PLASMA | ||||
| 1058 | GLUCOSE, CSF | ||||
| 1059 | GLUCOSE, PLEURAL FLUID | ||||
| 1060 | GLUCOSE, SYNOVIAL FLUID | ||||
| 1061 | GLUCOSE,PERICARDIAL FLUID | ||||
| 1062 | GLUTATHIONE | ||||
| 1063 | GLUTATHIONE | ||||
| 1064 | GLUTEN (F79) IGE | ||||
| 1065 | GLYCOHEMOGLOBIN, HBA1C | ||||
| 1066 | GLYCOMARK(R) | ||||
| 1067 | GLYCOPHORIN A,IHC W/INTRP | ||||
| 1068 | GLYPICAN 3, IHC W/INTERP. | ||||
| 1069 | GLYPICAN 3, IHC W/O INT. | ||||
| 1070 | GM-1 AB (IGG, IGM), EIA | ||||
| 1071 | GM1 ANTIBODY, ELISA | ||||
| 1072 | GONADOTROPIN RH | ||||
| 1073 | GQ1B IGG AB | ||||
| 1074 | GRANZYME B W/O INTERP | ||||
| 1075 | GRANZYME-B,IHC W/ INTERP | ||||
| 1076 | GRAPE (F259) IGE | ||||
| 1077 | GREEN PEPPER (F263)** | ||||
| 1078 | GROCOTT'S METHENAMINE SIL | ||||
| 1079 | GROWTH HORMONE | ||||
| 1080 | GROWTH HORMONE (GH) | ||||
| 1081 | H PYLORI AG,EIA,STOOL | ||||
| 1082 | H. INFLUENZAE TYPE B | ||||
| 1083 | H.PYLORI UBIT(R) | ||||
| 1084 | HALIBUT (F303) IGE | ||||
| 1085 | HALOPERIDOL | ||||
| 1086 | HALOPERIDOL | ||||
| 1087 | HAPTOGLOBIN | ||||
| 1088 | HAZELNUT (F17) IGE | ||||
| 1089 | HB E AG & AB, EIA | ||||
| 1090 | HB S AB, QUANT | ||||
| 1091 | HBSAG QUANT | ||||
| 1092 | HBV RESISTANCE, GENOTYPE | ||||
| 1093 | HBV SURFACE AG W/RFL | ||||
| 1094 | HBV VIRUS DNA, QUANT, PCR | ||||
| 1095 | HCG, ALTERNATE METHOD | ||||
| 1096 | HCV GENO 3 NS5A | ||||
| 1097 | HCV GENO 3 NS5A | ||||
| 1098 | HCV RNA GENOTYPE, LIPA | ||||
| 1099 | HCV RNA GENOTYPE, LIPA(R) | ||||
| 1100 | HCV RNA NS3 GENOTYPE | ||||
| 1101 | HCV RNA NS5A GENOTYPE | ||||
| 1102 | HCV RNA NS5B GENOTYPE | ||||
| 1103 | HCV RNA, PCR, QUANT | ||||
| 1104 | HCV, RNA, QUAN, PCR | ||||
| 1105 | HDL-CHOLESTEROL | ||||
| 1106 | HDV AB | ||||
| 1107 | HDV RNA, QN | ||||
| 1108 | HE4,OVARIAN CA MONITORING | ||||
| 1109 | HEAVY METALS PANEL, 24HR | ||||
| 1110 | HEAVY METALS PANEL, BLOOD | ||||
| 1111 | HEAVY METALS PANEL, BLOOD | ||||
| 1112 | HEAVY METALS PANEL, BLOOD | ||||
| 1113 | HEAVY METALS PNL #27,24HR | ||||
| 1114 | HEAVY METALS PNL,24HR U | ||||
| 1115 | HELICOBACTER PYLORI ANTIG | ||||
| 1116 | HELICOBACTER PYLORI, CULT | ||||
| 1117 | HELICOBACTER PYLORI, UREA | ||||
| 1118 | HEMATOLOGIC CULTURE | ||||
| 1119 | HEMOGLOBIN A1C | ||||
| 1120 | HEMOGLOBIN A1C | ||||
| 1121 | HEMOGLOBIN A2 | ||||
| 1122 | HEMOGLOBIN, FREE, PLASMA | ||||
| 1123 | HEMOGLOBIN, FREE, UR | ||||
| 1124 | HEMOGLOBIN, PLASMA | ||||
| 1125 | HEMOGLOBINOPATHY EVAL | ||||
| 1126 | HEMOGLOBINOPATHY EVALUATI | ||||
| 1127 | HEMOSIDERIN STAIN, URINE | ||||
| 1128 | HEMOSIDERIN STAIN, URINE | ||||
| 1129 | HEP B CORE AB (IGM) | ||||
| 1130 | HEP B CORE AB, (IGM) | ||||
| 1131 | HEP B SURFACE AB, QUANT | ||||
| 1132 | HEP B VIRUS DNA, QN PCR | ||||
| 1133 | HEP B VIRUS DRUG RESIST. | ||||
| 1134 | HEP C VIRAL RNA NS5A DRUG | ||||
| 1135 | HEP DELTA VIRUS AB | ||||
| 1136 | HEP INDUCED PLAT AB | ||||
| 1137 | HEPARIN ANTI-XA | ||||
| 1138 | HEPARIN INDUCED ANTIBODY | ||||
| 1139 | HEPARIN INDUCED PLATELET | ||||
| 1140 | HEPARIN-INDUCED PLATELET | ||||
| 1141 | HEPATIC FUNC PNL | ||||
| 1142 | HEPATITIS A IGM | ||||
| 1143 | HEPATITIS B SURFACE AG | ||||
| 1144 | HEPATITIS BE ANTIBODY | ||||
| 1145 | HEPATITIS BE ANTIBODY | ||||
| 1146 | HEPATITIS BE ANTIGEN | ||||
| 1147 | HEPATITIS BE ANTIGEN | ||||
| 1148 | HEPATITIS C VIRAL RNA | ||||
| 1149 | HEPATITIS C VIRAL RNA, QU | ||||
| 1150 | HEPATITIS E ANTIBODIES | ||||
| 1151 | HEPATITIS E ANTIBODY,IGM | ||||
| 1152 | HEPATITS E ANTIBODY (IGG) | ||||
| 1153 | HEPATOCELLULAR CARCINOMA | ||||
| 1154 | HER2 (HERCEPTEST(R)) IHC | ||||
| 1155 | HER2 (HERCEPTEST-TM) | ||||
| 1156 | HER-2, FISH, PARAFFIN BL | ||||
| 1157 | HER-2, FISH, PARAFFIN BL | ||||
| 1158 | HER-2,IHC W/RFL FISH | ||||
| 1159 | HER-2,IHC, W/ INTERP | ||||
| 1160 | HER-2,IHC, W/ INTERP | ||||
| 1161 | HEREDITARY HEMOCHROMATO- | ||||
| 1162 | HEREDITARY HEMOCHROMATOS | ||||
| 1163 | HERPES PROFILE # 1 | ||||
| 1164 | HERPES SIMPLEX TYPING | ||||
| 1165 | HERPES SIMPLEX VIRUS 1&2 | ||||
| 1166 | HERPES SIMPLEX VIRUS CULT | ||||
| 1167 | HERPES SIMPLEX VIRUS CULT | ||||
| 1168 | HERPES SIMPLEX,VARICELLA | ||||
| 1169 | HERPES SIMPLEX/VARICELLA- | ||||
| 1170 | HERPES VIRUS 6 DNA | ||||
| 1171 | HERPES VIRUS 6 DNA, QUANT | ||||
| 1172 | HERPES VIRUS 8 DNA,QUAL. | ||||
| 1173 | HERPESVIRUS 6 ABS(IG | ||||
| 1174 | HERPESVIRUS 6 DNA, QN PCR | ||||
| 1175 | HEV AB (IGG,IGM) | ||||
| 1176 | HEXAGONAL PHASE CONFIRM | ||||
| 1177 | HEXAGONAL PHASE CONFIRM | ||||
| 1178 | HEXAGONAL PHASE CONFIRM | ||||
| 1179 | HHV-8 IHC W/O INTERP. | ||||
| 1180 | HHV-8, IHC W/INTERPRETN. | ||||
| 1181 | HIGH-GRADE LYMPHOMA | ||||
| 1182 | HISTAMINE, 24 HR URINE | ||||
| 1183 | HISTAMINE, PLASMA | ||||
| 1184 | HISTAMINE,PLASMA | ||||
| 1185 | HISTONE ANTIBODIES | ||||
| 1186 | HISTONE ANTIBODIES | ||||
| 1187 | HISTONE ANTIBODY | ||||
| 1188 | HISTONE ANTIBODY | ||||
| 1189 | HISTOPLASMA AB,CF,ID,S | ||||
| 1190 | HISTOPLASMA AB,ID | ||||
| 1191 | HISTOPLASMA ANTIBODY,CF,S | ||||
| 1192 | HISTOPLASMA ANTIGEN | ||||
| 1193 | HISTOPLASMA ANTIGEN | ||||
| 1194 | HISTOPLASMA GALACTOMANNAN | ||||
| 1195 | HISTOPLASMIA ANTIBODY PNL | ||||
| 1196 | HIV 1 CORE TROPISM | ||||
| 1197 | HIV 1 CORE TROPISM | ||||
| 1198 | HIV AG/AB 4TH GEN W/REFLX | ||||
| 1199 | HIV-1 CORECEPTOR TROPISM | ||||
| 1200 | HIV-1 GENOTYPE | ||||
| 1201 | HIV-1 GENOTYPE | ||||
| 1202 | HIV-1 GENOTYPE (RTI,PI,IN | ||||
| 1203 | HIV-1 INTEGRASE GENOTYPE | ||||
| 1204 | HIV-1 INTEGRASE GENOTYPE | ||||
| 1205 | HIV-1 PCR/REFLEX GENOTYPE | ||||
| 1206 | HIV-1 PHENOSENSE COMP | ||||
| 1207 | HIV-1 RESISTANCE | ||||
| 1208 | HIV-1 RESISTANCE | ||||
| 1209 | HIV-1 RNA, QUAL TMA | ||||
| 1210 | HIV-1 RNA,QL TMA | ||||
| 1211 | HIV-1/2 AB DIF | ||||
| 1212 | HIV1/2 AB DIF,SUPPLEM,RFL | ||||
| 1213 | HIV-1/2 AB DIFF,SUPPLEMEN | ||||
| 1214 | HIV-1/2 AB DIFFERENTIATIO | ||||
| 1215 | HIV-1/2 AG/AB W/REFLEXES | ||||
| 1216 | HLA B*58:01 TYPING | ||||
| 1217 | HLA TYPING FOR CELIAC | ||||
| 1218 | HLA TYPING FOR CELIAC | ||||
| 1219 | HLA-A HIGH RESOLUTION | ||||
| 1220 | HLA-A,B,C LOW RESOL TYPIN | ||||
| 1221 | HLA-A,B,C TRANSPLANTATION | ||||
| 1222 | HLA-A29 DETERMINATION | ||||
| 1223 | HLA-B DETERM W/RFL TO HLA | ||||
| 1224 | HLA-B HIGH RESOLUTION | ||||
| 1225 | HLA-B*5701 TYPING | ||||
| 1226 | HLA-B*5701 TYPING | ||||
| 1227 | HLA-B27 ANTIGEN | ||||
| 1228 | HLA-B27 ANTIGEN | ||||
| 1229 | HLA-B27, DNA TYPING | ||||
| 1230 | HLA-B51 DETERMINATION | ||||
| 1231 | HLA-B51 DETERMINATION | ||||
| 1232 | HLA-C HIGH RESOLUTION | ||||
| 1233 | HLA-DQ TYPING FOR NARCOLE | ||||
| 1234 | HLA-DQB1 HIGH RESOLUTION | ||||
| 1235 | HLA-DRB1 HIGH RESOLUTION | ||||
| 1236 | HLA-DRB1 HIGH RESOLUTION | ||||
| 1237 | HLA-DRB1 LOW RESOLUTION | ||||
| 1238 | HMB45,IHC W/O INTERP | ||||
| 1239 | HOMOCYSTEINE | ||||
| 1240 | HOMOCYSTEINE, SERUM | ||||
| 1241 | HONEY BEE (I1) IGE | ||||
| 1242 | HONEY BEE (I1) IGE | ||||
| 1243 | HOP (F324) IGE | ||||
| 1244 | HOPS/FRUIT CONE IGE | ||||
| 1245 | HPV DNA, HIGH RISK | ||||
| 1246 | HPV DNA, HIGH RISK | ||||
| 1247 | HPV GENO 16,18/45 | ||||
| 1248 | HPV GENOTYPES 16, 18 | ||||
| 1249 | HPV GENOTYPES 16, 18 | ||||
| 1250 | HPV GENOTYPES 16, 18/45 | ||||
| 1251 | HPV GENOTYPES 16, 18/45 | ||||
| 1252 | HPV MRNA E6/E7 | ||||
| 1253 | HPV MRNA E6/E7 RFLX | ||||
| 1254 | HPV MRNA E6/E7,RECTAL | ||||
| 1255 | HPV MRNA E6E7 W/RFL | ||||
| 1256 | HPV RNA HR E6/E7 TMA | ||||
| 1257 | HPV,LOWHIGH RISK RNA | ||||
| 1258 | HPV,LOWHIGH RISK RNA | ||||
| 1259 | HS-CRP | ||||
| 1260 | HSV 1&2 REAL TIME QN PCR | ||||
| 1261 | HSV 1,2 DNA, PCR | ||||
| 1262 | HSV 1/2 (IGG) | ||||
| 1263 | HSV 1/2 AB (IGM),W/REFLEX | ||||
| 1264 | HSV 1/2 AB IGM W/RFL | ||||
| 1265 | HSV 1/2 AB IGM W/RFL | ||||
| 1266 | HSV 1/2 AG, DFA | ||||
| 1267 | HSV 1/2 DNA, QN PCR | ||||
| 1268 | HSV 1/2 IGG,TYPE SPECIFIC | ||||
| 1269 | HSV 1/2, IHC W/O INTERP | ||||
| 1270 | HSV 2 IGM TITER | ||||
| 1271 | HSV AB PNL | ||||
| 1272 | HSV CULTURE | ||||
| 1273 | HSV CULTURE W/RFL TYPING | ||||
| 1274 | HSV TYPES 1 & 2 W/INTERP. | ||||
| 1275 | HSV TYPES 1 & 2 W/O INT. | ||||
| 1276 | HSV, TYPE 1&2 DNA,QUANT. | ||||
| 1277 | HSV, TYPE 1/2 DNA, QL | ||||
| 1278 | HSV/VZV RAPID CULTURE | ||||
| 1279 | HSV1 IGM TITER | ||||
| 1280 | HTLV I/II DNA, QL | ||||
| 1281 | HTLV-I/II AB W/RFL CONF | ||||
| 1282 | HTLV-I/II ANTIBODY, W/ | ||||
| 1283 | HU AB W/RFL TITER, WB | ||||
| 1284 | HU AB, WB | ||||
| 1285 | HU AB, WESTERN BLOT SERUM | ||||
| 1286 | HU AB, WESTERN BLOT SERUM | ||||
| 1287 | HU, YO, & RI AB W/REFLEX | ||||
| 1288 | HU,YO,RI AB W/RFL TITR,WB | ||||
| 1289 | HUMAN ANTI-MOUSE AB(HAMA) | ||||
| 1290 | HUNTINGTON DISEASE | ||||
| 1291 | HUNTINGTON'S DISEASE MUTA | ||||
| 1292 | HYDROCODONE AND METAB, S | ||||
| 1293 | HYDROMORPHONE, SERUM | ||||
| 1294 | HYDROMORPHONE, URINE | ||||
| 1295 | HYPER PNEUMO EVAL | ||||
| 1296 | HYPER PNEUMO EVAL | ||||
| 1297 | HYPERSEN PNEUMONITIS SCR | ||||
| 1298 | HYPERSENSITIVITY PNEUMO | ||||
| 1299 | HYPERSENSITIVITY PNEUMONI | ||||
| 1300 | HYPOGLYCEMIC PANEL, S/P | ||||
| 1301 | HYPOGLYCEMIC PNL (Q)S/P | ||||
| 1302 | IA-2 ANTIBODY | ||||
| 1303 | IA-2 ANTIBODY | ||||
| 1304 | IA-2 ANTIBODY | ||||
| 1305 | ICS TITER | ||||
| 1306 | IGA SUBCLASSES | ||||
| 1307 | IGA,IHC W/ INTERP | ||||
| 1308 | IGD, SERUM | ||||
| 1309 | IGD, SERUM | ||||
| 1310 | IGE AB(ANTI-IGE IGG) | ||||
| 1311 | IGF BINDING PROTEIN-3 | ||||
| 1312 | IGF BINDING PROTEIN-3 | ||||
| 1313 | IGF I, LC/MS | ||||
| 1314 | IGF-2, LC/MS | ||||
| 1315 | IGF-2, LC/MS | ||||
| 1316 | IGF-I, LC/MS | ||||
| 1317 | IGG 4 | ||||
| 1318 | IGG IHC W/O INTERP | ||||
| 1319 | IGG INDEX&SYNTHESIS RATE | ||||
| 1320 | IGG SUBCLASSES | ||||
| 1321 | IGG SYNTHESIS RATE/INDEX, | ||||
| 1322 | IGG, CSF | ||||
| 1323 | IGG, CSF | ||||
| 1324 | IGG,IGA INDIRECT IMMUNOFL | ||||
| 1325 | IGG,IHC W/ INTERP | ||||
| 1326 | IGG,IHC W/O INTERP | ||||
| 1327 | IGG4, IHC W/INTERP | ||||
| 1328 | IGG4, IHC W/O INTERP | ||||
| 1329 | IGM,IHC W/ INTERP | ||||
| 1330 | IL-6, HIGHLY SENSITIVE | ||||
| 1331 | IMIPRAMINE | ||||
| 1332 | IMIPRAMINE | ||||
| 1333 | IMMEDIATE PT MIX | ||||
| 1334 | IMMEDIATE PTT-LA MIX | ||||
| 1335 | IMMUNE CELL FUNCTION | ||||
| 1336 | IMMUNE CELL FUNCTION | ||||
| 1337 | IMMUNE COMPLEX, C1Q | ||||
| 1338 | IMMUNE COMPLEX, C1Q | ||||
| 1339 | IMMUNOFIXATION ELECT. | ||||
| 1340 | IMMUNOFIXATION PROFILE X | ||||
| 1341 | IMMUNOFIXATION, SERUM | ||||
| 1342 | IMMUNOFIXATION, URINE | ||||
| 1343 | IMMUNOFIXATION,URINE | ||||
| 1344 | IMMUNOGLOB. G SUBCLASSES4 | ||||
| 1345 | IMMUNOGLOBULIN E | ||||
| 1346 | IMMUNOGLOBULIN E | ||||
| 1347 | IMMUNOGLOBULIN G SUBCLASS | ||||
| 1348 | IMMUNOGLOBULIN G SUBCLASS | ||||
| 1349 | IMMUNOGLOBULIN M(IGM) | ||||
| 1350 | IMMUNOHISTCHEM W/INTERP~2 | ||||
| 1351 | IMMUNOHISTCHEM W/INTERP~3 | ||||
| 1352 | IMMUNOHISTCHEM W/INTERP~4 | ||||
| 1353 | IMMUNOHISTCHEM W/INTERP~5 | ||||
| 1354 | IMMUNOHISTCHEM W/INTERP~8 | ||||
| 1355 | IMMUNOHISTOCHEM W/INTERP | ||||
| 1356 | IMMUNOHISTOCHEM W/O INT | ||||
| 1357 | INCUBATED PTT-LA MIX | ||||
| 1358 | INFLAMMATORY BOWEL DISEAS | ||||
| 1359 | INFLAMMATORY BOWEL DISEAS | ||||
| 1360 | INFLIXIMAB ADA IBD | ||||
| 1361 | INFLIXIMAB LEVEL/ADA, IBD | ||||
| 1362 | INFLIXIMAB LVL & ANTI DR | ||||
| 1363 | INFLUENZA A AND B AB,S | ||||
| 1364 | INFLUENZA A AND B RNA | ||||
| 1365 | INFLUENZA ANTIBODIES | ||||
| 1366 | INHIBIN A | ||||
| 1367 | INHIBIN A | ||||
| 1368 | INHIBIN B | ||||
| 1369 | INSULIN | ||||
| 1370 | INSULIN AUTOANTIBODIES | ||||
| 1371 | INSULIN AUTOANTIBODY | ||||
| 1372 | INSULIN, SERUM | ||||
| 1373 | INTERLEUKIN 2 (IL-2) | ||||
| 1374 | INTERLEUKIN 2R | ||||
| 1375 | INTERLEUKIN-10(IL-10)S | ||||
| 1376 | INTERLEUKIN-2 RECEPTOR | ||||
| 1377 | INTERLEUKIN-6,HIGHLY | ||||
| 1378 | INTERLEUKIN-6,HIGHLY | ||||
| 1379 | INTRINSIC FACTOR ANTIBODI | ||||
| 1380 | INTRINSIC FACTOR BLOCK AB | ||||
| 1381 | IODINE, 24-HOUR URINE | ||||
| 1382 | IODINE, 24-HOUR URINE | ||||
| 1383 | IODINE, RANDOM URINE | ||||
| 1384 | IODINE, RANDOM URINE | ||||
| 1385 | IODINE, SERUM/PLASMA | ||||
| 1386 | IRON STAIN, TISSUE | ||||
| 1387 | IRON, TOTAL | ||||
| 1388 | IRON, TOTAL, & IBC | ||||
| 1389 | IRON-LIVER TISSUE | ||||
| 1390 | ISLET CELL AB SCR W/TITER | ||||
| 1391 | ISLET CELL AB TITER | ||||
| 1392 | ISOPROPANOL, BLOOD | ||||
| 1393 | ITRACONAZOLE | ||||
| 1394 | ITRACONAZOLE, LC/MS/MS | ||||
| 1395 | JAK2 EXON 12 MUTATION ANA | ||||
| 1396 | JAK2 EXON 12 MUTATION ANA | ||||
| 1397 | JAK2 V617F CASCADING REFL | ||||
| 1398 | JAK2 V617F CASCADING REFL | ||||
| 1399 | JAK2 V617F MUTATION ANAL | ||||
| 1400 | JAK2 V617F MUTATION ANALY | ||||
| 1401 | JAK2 V617F MUTATION, QT | ||||
| 1402 | JC POLYOMA VIRUS DNA, QN | ||||
| 1403 | JC VIRUS DNA ULTRA QN | ||||
| 1404 | JC VIRUS DNA, QN PCR | ||||
| 1405 | JO-1 ANTIBODY | ||||
| 1406 | JO-1 ANTIBODY | ||||
| 1407 | JO-1 ANTIBODY | ||||
| 1408 | JO-1 ANTIBODY | ||||
| 1409 | JOHNSON GRASS (G10) IGE | ||||
| 1410 | KAPPA ISH W/O INTERP | ||||
| 1411 | KAPPA ISH W/O INTERP~2 | ||||
| 1412 | KAPPA,IHC W/ INTERP | ||||
| 1413 | KAPPA/LAMBDA LIGHT CHAIN | ||||
| 1414 | KAPPA/LAMBDA LIGHT CHAIN | ||||
| 1415 | KAPPA/LAMBDA LIGHT CHAINS | ||||
| 1416 | KAPPA/LAMBDA LT CHAIN | ||||
| 1417 | KAPPA/LAMBDA,FREE,SERUM | ||||
| 1418 | KAPPA/LAMBDA,ISH W/INTERP | ||||
| 1419 | KAPPA/LAMBDA,ISHW/O INTRP | ||||
| 1420 | KAPPA/LAMBDA,RATIO,U | ||||
| 1421 | KI-67,IHC W/ INTERP | ||||
| 1422 | KI-67,IHC W/O INTERP | ||||
| 1423 | KIT D816 | ||||
| 1424 | KIWI FRUIT (F84) IGE | ||||
| 1425 | KRAS MUTATION ANALYSIS | ||||
| 1426 | L. DESTRUCTOR (D71) IGE | ||||
| 1427 | L. PNEUMOPHILA CULTURE | ||||
| 1428 | LACOSAMIDE, LC/MS/MS | ||||
| 1429 | LACOSAMIDE,LC/MS/MS | ||||
| 1430 | LACTIC ACID, CSF | ||||
| 1431 | LACTOFERRIN, STOOL | ||||
| 1432 | LACTORFERRIN, QN, STOOL | ||||
| 1433 | LAMB (F88) IGE | ||||
| 1434 | LAMBDA,IHC W/ INTERP | ||||
| 1435 | LAMBERT-EATON SYNDROME AB | ||||
| 1436 | LAMOTRIGINE | ||||
| 1437 | LAMOTRIGINE | ||||
| 1438 | LATEX (K82) IGE | ||||
| 1439 | LATEX (K82) IGE | ||||
| 1440 | LD ISOENZYME PNL | ||||
| 1441 | LD, CSF | ||||
| 1442 | LD, PERICARDIAL FLUID | ||||
| 1443 | LD, SYNOVIAL FLUID | ||||
| 1444 | LDH ISOENZYME ELECTROPHOR | ||||
| 1445 | LEAD, 24 HR URINE | ||||
| 1446 | LEAD, 24-HOUR URINE | ||||
| 1447 | LEAD, BLOOD | ||||
| 1448 | LEAD, BLOOD | ||||
| 1449 | LEAD, BLOOD | ||||
| 1450 | LEGIONELLA ANTIGEN,EIA UR | ||||
| 1451 | LEGIONELLA CULTURE | ||||
| 1452 | LEGIONELLA DNA, QL | ||||
| 1453 | LEGIONELLA PNEUM AB IGG | ||||
| 1454 | LEGIONELLA PNEUM AB IGM | ||||
| 1455 | LEGIONELLA PNEUM AB IGM | ||||
| 1456 | LEGIONELLA PNEUMO AG, DFA | ||||
| 1457 | LEISHMANIA ANTIBODY (IGG) | ||||
| 1458 | LENTILS (F235) IGE | ||||
| 1459 | LENTILS (F235) IGE | ||||
| 1460 | LEPTOSPIRA AB, IGM | ||||
| 1461 | LEPTOSPIRA DNA, QL | ||||
| 1462 | LETTUCE (F215) IGE | ||||
| 1463 | LEU & LYM 18 MARKERS | ||||
| 1464 | LEU & LYM 22 MARKERS | ||||
| 1465 | LEU & LYM 23 MARKERS | ||||
| 1466 | LEU & LYM 24 MARKERS | ||||
| 1467 | LEU & LYM 25 MARKERS | ||||
| 1468 | LEU & LYM 9 MARKERS | ||||
| 1469 | LEUK&LYMP EVAL, 26 MARKR | ||||
| 1470 | LEUK&LYMP EVAL, 27 MARKR | ||||
| 1471 | LEUK&LYMP EVAL, 28 MARKR | ||||
| 1472 | LEUK&LYMP EVAL,14 MARKR | ||||
| 1473 | LEUK&LYMP EVAL,18 MARKR | ||||
| 1474 | LEUK&LYMP EVAL,22 MARKR | ||||
| 1475 | LEUK&LYMP EVAL,23 MARKR | ||||
| 1476 | LEUK&LYMP EVAL,24 MARKR | ||||
| 1477 | LEUK&LYMP EVAL,25 MARKR | ||||
| 1478 | LEUK&LYMP EVAL,26 MARKR | ||||
| 1479 | LEUK&LYMP EVAL,27 MARKR | ||||
| 1480 | LEUKOVANTAGE(TM) (AML) | ||||
| 1481 | LEUKOVANTAGE(TM) (AML) | ||||
| 1482 | LEUKOVANTAGE(TM),(MDS) | ||||
| 1483 | LEUKOVANTAGE(TM),(MDS) | ||||
| 1484 | LEUKOVANTAGE(TM),(MPN) | ||||
| 1485 | LEUKOVANTAGE(TM),(MPN) | ||||
| 1486 | LEVEL IV SURGICAL PATH | ||||
| 1487 | LEVETIRACETAM | ||||
| 1488 | LEVETIRACETAM | ||||
| 1489 | LGI1 ANTIBODY TEST | ||||
| 1490 | LGV DIFFERENTIATION | ||||
| 1491 | LIDOCAINE | ||||
| 1492 | LIDOCAINE | ||||
| 1493 | LIPID PANEL | ||||
| 1494 | LIPOPROTEIN (A) | ||||
| 1495 | LIPOPROTEIN ELECTROPHORES | ||||
| 1496 | LIPOPROTEIN FRACTION, IM | ||||
| 1497 | LIVER CYTOSOL (LC-1) AUTO | ||||
| 1498 | LIVER FIBROSIS, FIBROTEST | ||||
| 1499 | LIVER FIBROSIS, FIBROTEST | ||||
| 1500 | LIVER KIDNEY MICROSOME | ||||
| 1501 | LKM-1 ANTIBODY (IGG) | ||||
| 1502 | LMWH - SEROTONIN (14C) | ||||
| 1503 | LOBSTER (F80) IGE | ||||
| 1504 | LOBSTER (F80) IGE | ||||
| 1505 | LORAZEPAM (ATIVAN) | ||||
| 1506 | LP-PLA2 ACTIVITY | ||||
| 1507 | LUNG CA (NSCLC),ALK,FISH | ||||
| 1508 | LUNG CA (NSCLC),ROS1,FISH | ||||
| 1509 | LUNG CA(NSCLC), ALK, FISH | ||||
| 1510 | LUNG CA(NSCLC), ROS1, FIS | ||||
| 1511 | LUNG CANCER MUTATION PNL | ||||
| 1512 | LUNG CANCER MUTATION PNL | ||||
| 1513 | LUPUS ANTICOAG EVAL W/RFL | ||||
| 1514 | LUPUS ANTICOAGULANT SCREE | ||||
| 1515 | LYME DISEASE AB IGG,IGM | ||||
| 1516 | LYME DISEASE AB W/RFLX TO | ||||
| 1517 | LYME DISEASE AB, W/REFLEX | ||||
| 1518 | LYME DISEASE ANTIBODIES | ||||
| 1519 | LYME DISEASE DNA, REAL-TI | ||||
| 1520 | LYME DISEASEDNA QL,SF/CSF | ||||
| 1521 | LYME G/M,WB (CSF) | ||||
| 1522 | LYMPHOCYTE CLONALITY | ||||
| 1523 | LYMPHOCYTE CLONALITY PNL | ||||
| 1524 | LYMPHOCYTE SUBSET PANEL | ||||
| 1525 | LYMPHOCYTE SUBSET PANEL | ||||
| 1526 | LYMPHOCYTE SUBSET PANEL 1 | ||||
| 1527 | LYMPHOCYTE SUBSET PANEL 1 | ||||
| 1528 | LYMPHOCYTE SUBSET PANEL 2 | ||||
| 1529 | LYMPHOCYTE SUBSET PANEL 3 | ||||
| 1530 | LYMPHOCYTE SUBSET PANEL 4 | ||||
| 1531 | LYMPHOCYTE SUBSET PANEL 5 | ||||
| 1532 | LYMPHOCYTE SUBSET PANEL 5 | ||||
| 1533 | LYMPHOCYTE SUBSET PANEL 5 | ||||
| 1534 | LYMPHOGRANULOMA VENEREUM | ||||
| 1535 | LYNCH SYND TUMOR PNL,IHC | ||||
| 1536 | LYNCH SYND TUMOR PNL,IHC | ||||
| 1537 | LYNCH SYNDROME PANEL | ||||
| 1538 | LYNCH SYNDROME PANEL | ||||
| 1539 | LYNCHSYND TUMR,IHC INTERP | ||||
| 1540 | M TUBERCULOSIS, PCR, RESP | ||||
| 1541 | M. PNEUMONIAE ABS,IGG,IGM | ||||
| 1542 | M. PNEUMONIAE CULTURE | ||||
| 1543 | M. PNEUMONIAE DNA | ||||
| 1544 | MACADAMIA NUT (RF345)IGE | ||||
| 1545 | MAG AB W/RFL | ||||
| 1546 | MAG ANTIBODY (IGM), EIA | ||||
| 1547 | MAG IGM AB, EIA | ||||
| 1548 | MAGNESIUM | ||||
| 1549 | MAGNESIUM, 24 HOUR URINE | ||||
| 1550 | MAGNESIUM, 24U(W/O CREAT) | ||||
| 1551 | MAGNESIUM, MG/24H, NO CR | ||||
| 1552 | MAGNESIUM, RBC | ||||
| 1553 | MAG-SGPG AB (IGM), EIA | ||||
| 1554 | MAG-SGPG IGM AB, EIA | ||||
| 1555 | MAIL OUT TEST | ||||
| 1556 | MAIL OUT TEST | ||||
| 1557 | MAIZE/CORN (F8) IGE | ||||
| 1558 | MALARIA SMEAR | ||||
| 1559 | MALARIA/BABESIA/OTHER | ||||
| 1560 | MAMMAGLOBIN, IHC W/O INT. | ||||
| 1561 | MAMMAGLOBIN,IHC W/OINTERP | ||||
| 1562 | MANGANESE | ||||
| 1563 | MANGANESE, BLOOD | ||||
| 1564 | MANGANESE,BLOOD | ||||
| 1565 | MANGO (F91) IGE | ||||
| 1566 | MANGO FRUIT (F91) IGE | ||||
| 1567 | MANNOSE-BINDING LECTIN | ||||
| 1568 | MANTLE CELL LYMPHOMA | ||||
| 1569 | MARIJUANA BY GC/MS, UR | ||||
| 1570 | MARIJUANA BY GC/MS, URINE | ||||
| 1571 | MART-1,IHC W/O INTERP | ||||
| 1572 | MDMA/MDA, QUANT, URINE | ||||
| 1573 | MEASLES AB (IGM) | ||||
| 1574 | MEASLES ABS | ||||
| 1575 | MEASLES ANTIBODY (IGG) | ||||
| 1576 | MELANOMA,BRAF V600 MUTATN | ||||
| 1577 | MELANOMA,BRAF V600E,V600K | ||||
| 1578 | MEN1 SEQ, DEL/DUP | ||||
| 1579 | MEN1 SEQ, DEL/DUP | ||||
| 1580 | MENINGOEN COMP CSF | ||||
| 1581 | MENINGOENCEPHALITIS PANEL | ||||
| 1582 | MENINGOENCEPHALITIS PNL | ||||
| 1583 | MENTAL HEALTH PANEL | ||||
| 1584 | MERCURY | ||||
| 1585 | MERCURY, 24 HOUR URINE | ||||
| 1586 | MERCURY, 24-HOUR URINE | ||||
| 1587 | MERCURY, BLOOD | ||||
| 1588 | MERCURY, SERUM/PLASMA | ||||
| 1589 | MESQUITE TREE (T20) IGE | ||||
| 1590 | METANEPHRINES, 24HR URINE | ||||
| 1591 | METANEPHRINES, FRACT. | ||||
| 1592 | METANEPHRINES, LC/MS/MS | ||||
| 1593 | METANEPHRINES,FREE,PLASMA | ||||
| 1594 | METANEPHRINES,RANDM URINE | ||||
| 1595 | METHADONE BY GC/MS UR | ||||
| 1596 | METHADONE BY GC/MS, URINE | ||||
| 1597 | METHADONE, QUANT. GCMS | ||||
| 1598 | METHEMOGLOBIN | ||||
| 1599 | METHEMOGLOBIN | ||||
| 1600 | METHOTREXATE | ||||
| 1601 | METHYL ALCOHOL, BL OR SER | ||||
| 1602 | METHYLENETETRAHYDROFOLATE | ||||
| 1603 | METHYLMALONIC ACID | ||||
| 1604 | METHYLMALONIC ACID | ||||
| 1605 | METHYLMALONIC ACID GCMSMS | ||||
| 1606 | MHL1, IHC W/O INTERP | ||||
| 1607 | MI-2 AUTOANTIBODIES | ||||
| 1608 | MI-2 AUTOANTIBODIES | ||||
| 1609 | MIC (MICROSCAN) | ||||
| 1610 | MICROALBUMIN,24HR,W/CREAT | ||||
| 1611 | MICROSATELLITE INSTABILIT | ||||
| 1612 | MICROSPORIDIA EXAM | ||||
| 1613 | MICROSPORIDIA EXAM | ||||
| 1614 | MIMIMUM INHIBITORY CONC. | ||||
| 1615 | MINIMUM INHIBITORY CONCEN | ||||
| 1616 | MIRTAZAPINE, S,P | ||||
| 1617 | MISC CODE | ||||
| 1618 | MISC CODE | ||||
| 1619 | MISC372 | ||||
| 1620 | MISCELLANEOUS | ||||
| 1621 | MISC-NICHOLS INSTITUTE | ||||
| 1622 | MITOCHONDRIAL AB | ||||
| 1623 | MITOCHONDRIAL AB TITER | ||||
| 1624 | MITOCHONDRIAL AB TITER | ||||
| 1625 | MITOCHONDRIAL ANTIBODY SC | ||||
| 1626 | MITOTANE,SERUM/PLASMA | ||||
| 1627 | MITRAGYNINE (QUALITATIVE) | ||||
| 1628 | MITRAGYNINE, QL, UR | ||||
| 1629 | MITROCHONDRIAL M2 ANTIBO | ||||
| 1630 | MIXING STUDY | ||||
| 1631 | MMR (IGG) PANEL(MEASLES | ||||
| 1632 | MOC-31,IHC W/O INTERP | ||||
| 1633 | MOG AB W/RFL TITER,C | ||||
| 1634 | MOG AB W/RFL TITER,S | ||||
| 1635 | MOG AB W/RFL TITER,S | ||||
| 1636 | MOLD ID | ||||
| 1637 | MOLD ID~2 | ||||
| 1638 | MOLD ID~3 | ||||
| 1639 | MOLD IDENTIFICATION 1 | ||||
| 1640 | MOLD SUSCEPT, 5 DRUG | ||||
| 1641 | MOLD SUSCEPTIBILITY, 5 DR | ||||
| 1642 | MONOTEST | ||||
| 1643 | MORPHINE | ||||
| 1644 | MORPHINE FREE (UNCO | ||||
| 1645 | MOSQUITO (I71) IGE | ||||
| 1646 | MOSQUITO (I71) IGE | ||||
| 1647 | MOUSE EPITHELIA (E71) IGE | ||||
| 1648 | MOUSE SER PROT (E76) IGE | ||||
| 1649 | MOUSE UR PROT (E72) IGE | ||||
| 1650 | MPL MUT ANALYSIS (QUAL) | ||||
| 1651 | MPL MUTATION ANALYSIS | ||||
| 1652 | MPO IHC W/O INTERP | ||||
| 1653 | MPO, IHC W/ INTERP | ||||
| 1654 | MSA AB PANEL | ||||
| 1655 | MSA AB PANEL | ||||
| 1656 | MSI, HNPCC | ||||
| 1657 | MTB & RIFAM RESIS NON-SPU | ||||
| 1658 | MTB PROBE | ||||
| 1659 | MTB/RIF, PCR | ||||
| 1660 | MTB/RIF, PCR | ||||
| 1661 | MTHFR | ||||
| 1662 | MULTIPLE SCLEROSIS PNL 1 | ||||
| 1663 | MUM1, IHC W/O INTERP | ||||
| 1664 | MUM1,IHC W/INTERP | ||||
| 1665 | MUM1,IHC W/O INTERP | ||||
| 1666 | MUMPS AB IGG, EIA | ||||
| 1667 | MUMPS VIRUS ANTIBODIES | ||||
| 1668 | MURAMIDASE (LYSOZYME), S | ||||
| 1669 | MURAMIDASE, SERUM | ||||
| 1670 | MUSHROOM (F212) IGE | ||||
| 1671 | MUSK ANTIBODY TEST | ||||
| 1672 | MUSK ANTIBODY TEST | ||||
| 1673 | MUSK QN TITERS AB TEST | ||||
| 1674 | MVISTA(TM)BLASTOMYCES EIA | ||||
| 1675 | MYASTHENIA GRAVIS PANEL 1 | ||||
| 1676 | MYASTHENIA GRAVIS PANEL 2 | ||||
| 1677 | MYASTHENIA GRAVIS PANEL 2 | ||||
| 1678 | MYASTHENIA GRAVIS PANEL 3 | ||||
| 1679 | MYCO, BLOOD CULTURE | ||||
| 1680 | MYCOBACT SM CULT | ||||
| 1681 | MYCOBACTERIA CUL BLD | ||||
| 1682 | MYCOBACTERIA, CULTURE | ||||
| 1683 | MYCOBACTERIA, CULTURE,W/ | ||||
| 1684 | MYCOBACTERIUM AVIUM COMP. | ||||
| 1685 | MYCOBACTERIUM ID & SENS | ||||
| 1686 | MYCOBACTERIUM SLOW GROWER | ||||
| 1687 | MYCOPHENOLIC ACID | ||||
| 1688 | MYCOPHENOLIC ACID | ||||
| 1689 | MYCOPLASMA HOMINIS/UREAPL | ||||
| 1690 | MYCOPLASMA PNEUMONIA AB | ||||
| 1691 | MYCOPLASMA PNEUMONIAE | ||||
| 1692 | MYD88, MUTATION ANALYSIS | ||||
| 1693 | MYD88, MUTATION ANALYSIS | ||||
| 1694 | MYELIN ASSOCIATED GLYCOPR | ||||
| 1695 | MYELIN BASIC PROTEIN | ||||
| 1696 | MYELIN BASIC PROTEIN | ||||
| 1697 | MYELIN-ASSOCIATED GLYCO- | ||||
| 1698 | MYELOPEROXIDASE ANTIBODY | ||||
| 1699 | MYO D1, IHC W/O INTERP | ||||
| 1700 | MYOGENIN, IHC W/O INTERP | ||||
| 1701 | MYOGLOBIN, SERUM | ||||
| 1702 | MYOGLOBIN, SERUM | ||||
| 1703 | MYOGLOBIN, URINE | ||||
| 1704 | MYOGLOBIN, URINE | ||||
| 1705 | MYOSITIS ASSESSR PLUS JO- | ||||
| 1706 | MYVANTAGE(TM) PANEL | ||||
| 1707 | MYVANTAGE(TM) PANEL | ||||
| 1708 | NASH FIBROSURE | ||||
| 1709 | NATURAL KILLER CELLS | ||||
| 1710 | NEOCEREBELLAR DEGENERATIO | ||||
| 1711 | NEOCOMPLETE PARANEOPLASTI | ||||
| 1712 | NEOENCEPHALITIS PARANEOPL | ||||
| 1713 | NEURO AB, LINE BLOT | ||||
| 1714 | NEUROMYELITIS OPTICA(NMO) | ||||
| 1715 | NEURONAL NUCLEAR (HU) AB | ||||
| 1716 | NEUTROPHIL ANTIBODY | ||||
| 1717 | NEUTROPHIL ANTIBODY, FC | ||||
| 1718 | NEUTROPHIL FUNCTION, | ||||
| 1719 | NFP IHC W/O INTERP | ||||
| 1720 | NICKEL, SERUM/PLASMA | ||||
| 1721 | NICOTINE & MTB, S/P | ||||
| 1722 | NICOTINE & MTB, S/P | ||||
| 1723 | NICOTINE & MTB, S/P | ||||
| 1724 | NICOTINE AND COTININE,S/P | ||||
| 1725 | NICOTINE AND COTININE,U | ||||
| 1726 | NMDA RECEPTOR AB | ||||
| 1727 | NMDA RECEPTOR AB TEST | ||||
| 1728 | N-METHYLHISTAMINE, U | ||||
| 1729 | No Service Code | ||||
| 1730 | NOREPINEPHRINE, PLASMA | ||||
| 1731 | NOROVIRUS RNA, RT-PCR | ||||
| 1732 | NORTRIPTYLINE | ||||
| 1733 | NORTRIPTYLINE | ||||
| 1734 | NOTCH3 SEQ TEST | ||||
| 1735 | NOTCH3 SEQ TEST | ||||
| 1736 | NPM MUTATION, CELL-BASED | ||||
| 1737 | NPM(EXON 12) MUT ANALYSIS | ||||
| 1738 | NRAS MUTATION ANALYSIS | ||||
| 1739 | NRAS MUTATION ANALYSIS | ||||
| 1740 | NSE, IHC W/O INTERP | ||||
| 1741 | N-TELOPEPTIDE (NTX), 24 H | ||||
| 1742 | N-TELOPEPTIDE (NTX), 24 U | ||||
| 1743 | O&P CONCENTRATE & STAIN | ||||
| 1744 | OAK WHITE IGE | ||||
| 1745 | OAT (F7) IGE | ||||
| 1746 | OAT (F7) IGE | ||||
| 1747 | OLANZAPINE | ||||
| 1748 | OLIGOCLONAL BANDS (IGG), | ||||
| 1749 | OLIGOCLONAL BANDS, IGG | ||||
| 1750 | OMEGA FATTY ACIDS | ||||
| 1751 | ONION (F48) IGE | ||||
| 1752 | ONION (F48) IGE | ||||
| 1753 | OPIATES BY GC/MS, URINE | ||||
| 1754 | OPIATES, CONFIRM BY GCMS | ||||
| 1755 | OPIATES, EXPANDED BY GC/M | ||||
| 1756 | ORANGE (F33) IGE | ||||
| 1757 | ORANGE (F33) IGE | ||||
| 1758 | ORG ID 1 | ||||
| 1759 | ORG ID 1 | ||||
| 1760 | ORG ID 2 | ||||
| 1761 | OSMOLALITY | ||||
| 1762 | OSMOLALITY, FECES | ||||
| 1763 | OSMOLALITY, FECES |
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .